IndraLab

Statements



reach
"Furthermore, the ectopic expression of USP53 inhibited the proliferation, migration and invasion, and induced the apoptosis of HCC cells."

reach
"Overexpression of USP53 inhibited the proliferation and migration of HCC cells in vitro."

reach
"Taken together, USP53 inhibited the proliferation and migration of HCC cells by inducing the blocking at G1/S phases and increasing cell apoptosis."

reach
"Then, we performed immunohistochemical staining on the tissues of patients with renal clear cell carcinoma and found that the expression of USP53 in tumor tissues was significantly lower than paracancerous tissues (Figure 1F).3.2 Overexpression USP53 inhibits the growth and proliferation of ccRCC."

reach
"Through CCK‐8 assay, we found that overexpression of USP53 in Caki‐1 and 786‐O cells significantly inhibited cell proliferation (Figure 2C,D)."

reach
"BrdU cell proliferation assay was also used to test the proliferative ability of cells, and the proliferation of USP53 overexpression cells was inhibited compared with control (Figure 2G,H).3.3 Knockdown USP53 promotes the growth and proliferation of ccRCC."

reach
"In addition, USP53 also inhibited the proliferation and migration of clear renal cell carcinoma cells by inactivating the NF-κB pathway [9]."

reach
"The proliferation and metastasis of ccRCC were significantly inhibited by USP53 in vitro."

reach
"Furthermore, forced expression of USP53 inhibited the proliferation, migration and invasion, and induced apoptosis in HCC cell lines both in vitro and in vivo."

reach
"Functionally, ectopic USP53 expression reduced cell proliferation and cell migration in vitro and vice versa."

reach
"Downregulation of USP53 also promote cell proliferation in vivo."

reach
"USP53 Promotes Cell Proliferation in TNBC."

reach
"The results showed that knockdown of USP53 significantly reduced TNBC cell proliferation (Figure 2c,d,g)."

reach
"Overexpression of USP53 accelerated TNBC cell proliferation (Figure 2f,h)."

reach
"As shown, the knockdown of USP53 significantly reduced the proliferation of mouse mammary tumors (Figure 2m)."

reach
"Taken together, USP53 inhibited HCC growth in vivo by impairing cell proliferation and enhancing cell apoptosis."

reach
"Because upregulation of USP53 promoted proliferation, migration, invasion, and EMT in TNBC, we investigated whether this was due to the regulation of CRKL by USP53."

reach
"Cell proliferation assays showed that USP53 knockdown inhibited cell proliferation and increased chemosensitivity to PTX in MDA-MB-231 cells (Figure 7c)."

reach
"Consistently, USP53 overexpression promoted cell proliferation and decreased chemosensitivity to PTX in MDA-MB-468 cells (Figure 7d)."

reach
"Functionally, USP53 promotes TNBC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT)."
USP53 affects CRKL
1 | 19 5
USP53 binds CRKL.
1 | 6 5
1 | 6 5

sparser
"Mechanistically, USP53 directly binds CRKL to stabilize and deubiquitinate it, thereby preventing CRKL degradation."

sparser
"USP53 Binds, Stabilizes, and Deubiquitinates CRKL."

sparser
"Coimmunoprecipitation analysis showed that endogenous USP53 could bind CRKL ( xref l,m)."

reach
"Our study shows that USP53 can directly bind, stabilize, and deubiquitinate CRKL and further promote proliferation, migration, invasion, and EMT in TNBC.Recent research has demonstrated that CRKL can control EMT, impacting the development and spread of malignancies."

sparser
"Taken together, USP53 can directly bind, stabilize, and deubiquitinate CRKL."

reach
"USP53 Binds, Stabilizes, and Deubiquitinates CRKL."

reach
"Mechanistically, USP53 directly binds CRKL to stabilize and deubiquitinate it, thereby preventing CRKL degradation."

reach
"We explored the STRING database to determine the precise mechanism by which USP53 controls EMT and discovered that USP53 can directly bind CRKL (Figure 4a)."

sparser
"However, further study is needed to determine the sites by which USP53 interacts with CRKL and identify strategies that can be applied to regulate the degree of CRKL deubiquitination by USP53."

No evidence text available
USP53 deubiquitinates CRKL.
| 10
USP53 deubiquitinates CRKL. 10 / 10
| 10

reach
"Overall, we discovered that USP53 deubiquitinates CRKL, encourages tumor development and metastasis, and reduces chemosensitivity in TNBC."

reach
"To date, the regulatory function of USP53 in EMT has not been made explicit.In this study, we verified that USP53 is a deubiquitinating enzyme for CRKL that directly binds, stabilizes, and deubiquitinates CRKL."

reach
"In conclusion, USP53 plays an important role in TNBC progression by deubiquitinating CRKL."

reach
"USP53 Binds, Stabilizes, and Deubiquitinates CRKL."

reach
"As a deubiquitinase, USP53 may control CRKL by deubiquitinating CRKL."

reach
"USP53 may regulate the proliferation and metastasis of TNBC by deubiquitinating CRKL."

reach
"Here, we found that CRKL can be deubiquitinated by USP53."

reach
"The overexpression of USP53 in TNBC promotes the deubiquitination of CRKL and tumor growth and metastasis in TNBC."

reach
"In summary, we found that USP53 can deubiquitinate CRKL, thus regulating tumor proliferation, metastasis, and sensitivity to chemotherapy in TNBC (Figure 7m)."

reach
"Notably, USP53 is the first DUB found to deubiquitinate CRKL."
USP53 increases the amount of CRKL.
| 2
USP53 increases the amount of CRKL. 2 / 2
| 2

reach
"USP53 knockdown reduced CRKL expression in MDA-MB-231 cells, and USP53 overexpression elevated the expression of CRKL in MDA-MB-468 cells (Figure 4f,g)."

reach
"Taken together, USP53 promotes the process of EMT in TNBC partly by regulating CRKL protein expression."
USP53 inhibits CRKL.
| 1
USP53 inhibits CRKL. 1 / 1
| 1

reach
"The proteasome inhibitor MG132 significantly attenuated the downregulation of CRKL induced by USP53 knockdown, whereas CRKL expression generated by USP53 knockdown was not significantly impacted by the autophagy inhibitor 3-MA (Figure 5c,d)."
| 1 17
| 1 15

reach
"USP53 induced apoptosis in HCC cells through stabilization of CYCS."

reach
"To further confirm whether USP53 induced cell apoptosis through CYCS, we simultaneously knocked down USP53 and overexpressed CYCS in HCC cells (Supplementary Fig. 3), and found the apoptotic rate was significantly enhanced compared to knocking down USP53 alone (Fig. 6C)."

reach
"Furthermore, the ectopic expression of USP53 inhibited the proliferation, migration and invasion, and induced the apoptosis of HCC cells."

reach
"Furthermore, forced expression of USP53 inhibited the proliferation, migration and invasion, and induced apoptosis in HCC cell lines both in vitro and in vivo."

reach
"Of note, Usp53 is known to promote apoptosis , and Mrpl20 is a component of the mitoribosome complex, the dysfunction of which is liked to impair cell cycle processes ."

reach
"Finally, the overexpression of CYCS compensated for the decreased apoptotic rates in cells with USP53 knocked down, suggesting that USP53 induced the apoptosis in HCC cells through the deubiquitination of CYCS."

reach
"Zhao et al. showed that USP53 interacted with FKBP51 in lung adenocarcinoma cells, and induced apoptosis via the AKT pathway [8]."

eidos
"USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51-AKT1 signaling ."

reach
"USP53 induces apoptosis of hepatocellular carcinoma cells through deubiquitination of cytochrome C [8] and is a tumor suppressive factor in esophageal carcinoma [9], lung adenocarcinoma [10], and renal clear cell carcinoma [11], but it has a significant inhibitory effect on the radiosensitivity of human cervical cancer [12]."

reach
"USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51-AKT1 signaling."
| 2

reach
"In their research, USP53, as a tumor suppressor, inhibited the proliferation and migration of Huh-7 and HCCLM3 cells in vitro, promoting apoptosis by deubiquitinating and stabilizing cytochrome C (a key apoptotic protein) to prolong its active time and restrained the growth of transplanted tumor in vivo."

reach
"Gain- and loss-of-function experiments demonstrated USP53 inhibited proliferation, clonogenesis, cell cycle and xenograft growth, as well as induced apoptosis and mitochondrial damage of breast cancer cells."
USP53 affects CYCS
6 | 7 3
USP53 binds CYCS.
6 | 2 3
6 | 2 3

No evidence text available

reach
"Finally, GST pull-down assay was used to verify the direct interaction between USP53 and CYCS (Fig. 4H)."

reach
"The experimental data obtained in this study also demonstrated that the binding between USP53 and CYCS occurred in the cytoplasm."

sparser
"Finally, GST pull-down assay was used to verify the direct interaction between USP53 and CYCS (Fig. xref )."

sparser
"As shown in Supplementary Fig. xref , USP53 interacted with CYCS and promotes the deubiquitination and stabilization of CYCS in HCC cells, which further activated the apoptosis cascade and inhibits the progression of tumors."

sparser
"Furthermore, our experimental data showed that USP53 interacts with the CYCS protein."

No evidence text available

No evidence text available

No evidence text available

No evidence text available
USP53 deubiquitinates CYCS.
| 3
USP53 deubiquitinates CYCS. 3 / 3
| 3

reach
"USP53 also deubiquitinates cytochrome c and promotes apoptosis of hepatoma cells [8]."

reach
"Ubiquitination CO-IP further showed that overexpression of USP53 led to deubiquitination of CYCS in the HEK-293T, Huh-7 and HCCLM3 cells (Fig. 5M)."

reach
"As shown in Supplementary Fig. 5, USP53 interacted with CYCS and promotes the deubiquitination and stabilization of CYCS in HCC cells, which further activated the apoptosis cascade and inhibits the progression of tumors."
USP53 activates CYCS.
| 2
USP53 activates CYCS. 2 / 2
| 2

reach
"USP53 upregulated CYCS and its downstream genes through direct interaction."

reach
"USP53 overexpression increased the stability of CYCS in HCC cells following cycloheximide treatment."
| 12
| 8

reach
"The overexpression of USP53 in TNBC promotes the deubiquitination of CRKL and tumor growth and metastasis in TNBC."

reach
"USP53 Promotes TNBC Cell Metastasis."

reach
"Taken together, USP53 promotes metastasis and EMT in TNBC."

reach
"Here, we show that the deubiquitinase USP53 contributes to tumor growth and metastasis in TNBC."

reach
"Ubiquitin-specific peptidase 53 (USP53) prevents the inactivation of the NF-κB pathway by reducing ubiquitination of IκBα, thereby further inhibiting ccRCC proliferation and metastasis (Gui et al., 2021)."

reach
"In this study, we found that USP53 promoted the growth and metastasis of TNBC."

reach
"USP53 can inhibit the complex of p50 and p65 by deubiquitinizing IκBα, thereby inhibiting the activity of the NF-κB pathway and ultimately inhibiting the proliferation and metastasis of ccRCC [92]."

reach
"Additionally, the knockdown of USP53 suppressed proliferation, EMT, and metastasis and enhanced the paclitaxel response of TNBC cells."
| 4

reach
"The proliferation and metastasis of ccRCC were significantly inhibited by USP53 in vitro."

reach
"In summary, our data showed that USP53 inhibits ccRCC proliferation and metastasis through NF‐κB pathway inactivation."

reach
"In addition, USP53 knockdown promoted ccRCC growth and metastasis."

reach
"USP53 inhibited the proliferation and metastasis of ccRCC cells (786-O and Caki-1) via the NF-κB pathway in vitro, and the knockdown of USP53 promoted the growth of transplanted tumors in nude mice with ccRCC."
CYCS affects USP53
6 | 3 3
CYCS binds USP53.
6 | 2 3
6 | 2 3

No evidence text available

reach
"Finally, GST pull-down assay was used to verify the direct interaction between USP53 and CYCS (Fig. 4H)."

reach
"The experimental data obtained in this study also demonstrated that the binding between USP53 and CYCS occurred in the cytoplasm."

sparser
"Finally, GST pull-down assay was used to verify the direct interaction between USP53 and CYCS (Fig. xref )."

sparser
"As shown in Supplementary Fig. xref , USP53 interacted with CYCS and promotes the deubiquitination and stabilization of CYCS in HCC cells, which further activated the apoptosis cascade and inhibits the progression of tumors."

sparser
"Furthermore, our experimental data showed that USP53 interacts with the CYCS protein."

No evidence text available

No evidence text available

No evidence text available

No evidence text available
CYCS activates USP53.
| 1
CYCS activates USP53. 1 / 1
| 1

reach
"As shown in Fig. 5E, CYCS was upregulated in the cells overexpressing USP53."
CRKL affects USP53
1 | 6 5
1 | 6 5

sparser
"Mechanistically, USP53 directly binds CRKL to stabilize and deubiquitinate it, thereby preventing CRKL degradation."

sparser
"USP53 Binds, Stabilizes, and Deubiquitinates CRKL."

sparser
"Coimmunoprecipitation analysis showed that endogenous USP53 could bind CRKL ( xref l,m)."

reach
"Our study shows that USP53 can directly bind, stabilize, and deubiquitinate CRKL and further promote proliferation, migration, invasion, and EMT in TNBC.Recent research has demonstrated that CRKL can control EMT, impacting the development and spread of malignancies."

sparser
"Taken together, USP53 can directly bind, stabilize, and deubiquitinate CRKL."

reach
"USP53 Binds, Stabilizes, and Deubiquitinates CRKL."

reach
"Mechanistically, USP53 directly binds CRKL to stabilize and deubiquitinate it, thereby preventing CRKL degradation."

reach
"We explored the STRING database to determine the precise mechanism by which USP53 controls EMT and discovered that USP53 can directly bind CRKL (Figure 4a)."

sparser
"However, further study is needed to determine the sites by which USP53 interacts with CRKL and identify strategies that can be applied to regulate the degree of CRKL deubiquitination by USP53."

No evidence text available
USP53 affects RIPK1
| 11
USP53 binds RIPK1.
| 10
| 10

sparser
"Targeting the USP53RIPK1 axis could be a potential strategy for the treatment of alcohol-associated myocardial damage."

sparser
"Our work elucidates the pathogenic role of the USP53RIPK1 signaling axis in EtOH-induced cardiomyopathy, providing a novel molecular target for therapeutic intervention."

sparser
"USP53 interacts with the intermediate domain of RIPK1 via its C-terminal region."

sparser
"Cotransfection of USP53 mutants and HA-tagged RIPK1 in HEK-293T cells showed that both the full length and the C terminus of USP53 could interact with RIPK1, but not the N terminus of USP53, which indicated that the C terminus of USP53 was essential for interacting with RIPK1 (Fig. xref J)."

sparser
"Subsequently, USP53 interacted with the intermediate domain of RIPK1 and removed K63-linked ubiquitination at lysine-377 (K377), facilitating RIPK1 phosphorylation and triggering downstream apoptotic and necroptotic pathways in cardiac cells."

sparser
"USP53 directly binds to RIPK1 and triggers its kinase activity by removing the K63-linked ubiquitin chain at the lysine-377 (K377) site, which in turn drives apoptosis and necroptosis, and exacerbates ACM."

sparser
"However, Co-IP assay revealed that the K377R mutation did not affect the interaction between RIPK1 and USP53 (Fig. xref G)."

sparser
"These results highlight the USP53RIPK1 signaling axis as a potential therapeutic target for mitigating ACM progression."

sparser
"These findings revealed the critical role of USP53RIPK1 interaction in driving alcoholic CM injury and ACM."

sparser
"Mechanistically, USP53 directly interacts with RIPK1 and activates RIPK1 kinase activity by disrupting K63-linked ubiquitination at K377, the major K63 ubiquitination site in human RIPK1 [ xref ]."
USP53 activates RIPK1.
| 1
USP53 activates RIPK1. 1 / 1
| 1

sparser
"These results suggest that USP53 activates RIPK1 by the deubiquitination of K63-linked Ub at K377 of RIPK1."

reach
"Therefore, it can be explained that the gene USP53 can inhibit the migration and invasion of renal cancer cells."

reach
"Furthermore, the ectopic expression of USP53 inhibited the proliferation, migration and invasion, and induced the apoptosis of HCC cells."

reach
"Furthermore, forced expression of USP53 inhibited the proliferation, migration and invasion, and induced apoptosis in HCC cell lines both in vitro and in vivo."

reach
"In the study of USP53-mediated IκB stabilization, researchers found that USP53 inhibits the proliferation, invasion, and migration of renal cancer cells in vitro and in vivo (53)."

reach
"The results showed that USP53 knockdown significantly promoted the migration and invasion of renal cancer cells Caki‐1 and 786‐O cells (Figure 5C,D)."

reach
"Wound-healing and transwell assays showed that the overexpressed USP53 significantly inhibited the migration (Fig. 2D–G) and invasion (Fig. 2H, I) of HCC cells in vitro."

reach
"EDU cell proliferation imaging assay and BrdU cell proliferation assay also showed that the proliferation of ccRCC after USP53 knockdown was promoted compare with shGFP (Figure 3E–H).3.4 Overexpression USP53 inhibits migration and invasion of ccRCC."
| 4

reach
"The ability of cell migration and invasion was tested via Transwell assays, we found fewer migrated cells on the Transwell chamber surface compared to the controls after overexpression USP53 (Figure 4C,D), the quantitative results are at the bottom of the picture.3.5 Knockdown USP53 promotes migration and invasion of ccRCC."

reach
"Functionally, USP53 promotes TNBC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT)."

reach
"Knockdown of CRKL Can Reverse Cell Proliferation, Migration, and Invasion Induced by USP53 Upregulation."

reach
"Because upregulation of USP53 promoted proliferation, migration, invasion, and EMT in TNBC, we investigated whether this was due to the regulation of CRKL by USP53."
USP53 affects FBXO31
2 | 4 5
2 | 4 4

sparser
"To examine whether USP53 interacted with FBXO31 in hBMSCs, co-IP and western blotting were performed using wild-type and mutant FBXO31 (myc-FBXO31ΔF), the latter of which harbored a deletion of the F-box domain, which mediates binding to Skp1 and Cul1."

reach
"Additionally, we confirmed that USP53 overexpression promoted osteogenesis in hBMSCs by activating the Wnt and beta-catenin signaling pathway in vitro and that USP53 bound with FBXO31 during the osteogenic differentiation of hBMSCs."

sparser
"In addition to mediate β‐catenin directly, USP53 binding with FBXO31 further stabilizes β‐catenin in promotion of Wnt/β‐catenin activation in BMSCs and bone regeneration [ xref ]."

reach
"In addition to mediate β‐catenin directly, USP53 binding with FBXO31 further stabilizes β‐catenin in promotion of Wnt/β‐catenin activation in BMSCs and bone regeneration [143]."

reach
"Mass spectrometry showed that USP53 interacted with F-box only protein 31 (FBXO31) to promote proteasomal degradation of beta-catenin."

reach
"To examine whether USP53 interacted with FBXO31 in hBMSCs, co-IP and western blotting were performed using wild-type and mutant FBXO31 (myc-FBXO31DeltaF), the latter of which harbored a deletion of the F-box domain, which mediates binding to Skp1 and Cul1."

sparser
"As shown in Fig. xref , USP53 and FBXO31 bound with each other in hBMSCs."

sparser
"Additionally, we confirmed that USP53 overexpression promoted osteogenesis in hBMSCs by activating the Wnt/β-catenin signaling pathway in vitro and that USP53 bound with FBXO31 during the osteogenic differentiation of hBMSCs."

No evidence text available

No evidence text available
| 1

sparser
"First, we examined the mechanism through which FBXO31 regulated the stability of β-catenin, a key mediator of the Wnt signaling pathway xref and bone formation during osteogenic differentiation xref , using co-IP and western blot assays with wild-type FBXO31 and myc-FBXO31ΔF. As shown in Fig. xref , FBXO31 specifically interacted with β-catenin, Skp1, and USP53."
USP53 affects TJP2
1 | 3 6
USP53 binds TJP2.
1 | 2 6
1 | 2 5

sparser
"Interactions of USP53 and TJP2 were investigated by immunofluorescence and co-immunoprecipitation."

sparser
"USP53 interacts with TJP2."

sparser
"It has been suggested that USP53 may interact with TJP2 and regulate its function in the liver."

No evidence text available

reach
"Instead of binding with Ub, USP53 interacts with ZO-1 and ZO-2 as a part of the tight junction complex."

sparser
"Research in mice has demonstrated that USP53 interacts with TJP2 (ZO-2), contributing to the integrity of tight junctions (Figure xref )[ xref , xref ]."

reach
"USP53 interacts with the tight-junction constituent TJP2."

sparser
"USP53 interacts with the tight-junction constituent TJP2."
USP53 binds TJP1 and TJP2. 1 / 1
| 1

sparser
"Instead of binding with Ub, USP53 interacts with ZO-1 and ZO-2 as a part of the tight junction complex (Kazmierczak et al., xref )."
USP53 activates TJP2.
| 1
USP53 activates TJP2. 1 / 1
| 1

reach
"Liver Usp53 cKO causes upregulation of hepatobiliary Tjp2, with biochemical and histologic features that largely mimic those of liver Tjp2 cKO, implying that USP53 deficiency may share similar mechanism to TJP2 deficiency."
USP53 affects MSR1
| 10
USP53 binds MSR1.
| 4
| 3

reach
"Furthermore, Co-IP experiments confirmed endogenous and exogenous interactions between USP53 and SR-A."

reach
"This is consistent with our finding that USP53 interacts with, and deubiquitinates SR-A, thereby stabilizing SR-A and promoting the formation of SMC-derived foam cells."

reach
"Additionally, the interaction between USP53 and SR-A in HASMCs was enhanced by exogenous rDKK1 treatment (Figure 7G) or co-culturing with ECs overexpressing DKK1 (Lenti-GFP-DKK1 EC, Figure 7H)."
USP53 binds MSR1 and USP domain. 1 / 1
| 1

reach
"RNA sequencing revealed that DKK1-induced SR-A upregulation in SMCs is dependent on Ubiquitin-specific Protease 53 (USP53), which bound to SR-A via its USP domain and cysteine at position 41, exerting deubiquitination to maintain the stability of the SR-A protein by removing the K48 ubiquitin chain and preventing proteasomal pathway degradation, thereby mediating the effect of DKK1 on lipid uptake in SMCs."
USP53 ubiquitinates MSR1.
| 2
USP53 leads to the ubiquitination of MSR1. 2 / 2
| 2

reach
"To test whether USP53 modulates SR-A ubiquitination, HEK293T cells were co-transfected with HA-tagged ubiquitin (Ub), Myc-tagged SR-A, and dose-dependent Flag-tagged USP53 plasmids."

reach
"In addition, by using co-culturing HASMCs transfected with USP53-siRNA and HAECs transfected with Lenti-GFP-DKK1, we found that USP53 knockdown reversed the downregulation of SR-A ubiquitination induced by endothelial DKK1 in co-cultured HASMCs (Figure 7L)."
USP53 increases the amount of MSR1.
| 2
USP53 increases the amount of MSR1. 2 / 2
| 2

reach
"Importantly, USP53 knockdown significantly attenuated the rDKK1-induced upregulation of SR-A expression in SMCs (Figure 6J), and reduced the rDKK1-induced lipid accumulation and DIL-oxLDL uptake (Figure 6K, 6L)."

reach
"USP53 upregulates the SR-A expression via a deubiquitinating function, leading to stronger and more stable promotion of foam cell formation and AS."
USP53 deubiquitinates MSR1.
| 2
USP53 deubiquitinates MSR1. 2 / 2
| 2

reach
"This is consistent with our finding that USP53 interacts with, and deubiquitinates SR-A, thereby stabilizing SR-A and promoting the formation of SMC-derived foam cells."

reach
"Endogenous and exogenous ubiquitination, in addition to in vitro ubiquitination assays, have revealed that SR-A is deubiquitinated by USP53 through its deubiquitinating enzyme via K48-linked polyubiquitination, which inhibits protein degradation via the 26S proteasome pathway.Thus, herein, we demonstrate that low shear stress-induced endothelial DKK1 promotes the formation of co-cultured SMC-derived foam cells, which is primarily mediated by the USP53-inhibited proteasomal degradation of SR-A."
USP53 affects DDB2
2 | 2 5
2 | 2 5

sparser
"Interestingly, we also confirmed that USP53 interacts with DDB2 by co-immunoprecipitation ( xref )."

sparser
"Thus, the physiological relevance of USP53-DDB2 interactions is unclear."

No evidence text available

reach
"XREF_BIBR USP53 interacts with DDB2, but knockdown of USP53 has no effect on DDB2 stability."

No evidence text available

sparser
"For instance, USP9X influences apoptosis by targeting MCL-1 [ xref , xref ] or regulates TGFβ signaling via KDM4C [ xref ], while USP7 and USP24 target p53 [ xref , xref ], USP13 targets PTEN [ xref ], USP53 interacts with DNA damage binding protein 2 (DDB2) [ xref ], and USP28 modulates HIF-1α [ xref ]."

sparser
"Damage-specific DNA binding protein 2 (DDB2) is involved in nucleotide excision repair, which can repair DNA damage, and prevent gene mutation and tumorigenesis. xref Zou et al showed that knockdown of DDB2 expression in human lung cancer cells decreases the G2 phase and the repair efficiency of homologous recombination to increase the sensitivity of lung cancer cells to radiotherapy. xref Damage-specific DNA binding protein has been shown to interact with USP53, although the physiological relevance of USP53DDB2 interactions remains unclear. xref In this study, we knocked down USP53 to provide evidence that the relationship between USP53 and DDB2 increases the radiosensitivity of cervical squamous cell carcinoma."

reach
"Interestingly, we also confirmed that USP53 interacts with DDB2 by co-immunoprecipitation (XREF_FIG)."

sparser
"USP53 interacts with DDB2, but knockdown of USP53 has no effect on DDB2 stability."
USP53 affects Cholestasis
| 10
USP53 activates Cholestasis.
| 7
| 7

reach
"Previous studies identified a new type of normal-GGT cholestasis caused by autosomal recessive pathogenic variants in ubiquitin-specific peptidase 53 (USP53)."
| PMC

reach
"Mutations in the USP53 gene can cause cholestasis and deafness and may also be a potential cause of schizophrenia."

reach
"Here, we report a novel truncating mutation in the ubiquitin-specific peptidase gene ( USP53 ) causing low-γ-GT (GGT) cholestasis."

reach
"Mutations in the USP53 gene in humans can cause cholestasis [4,5,6], hearing loss [7], and other conditions."

reach
"However, we cannot be sure that hepatic hemangiomas are the specific symptom of cholestasis caused by mutations in USP53 gene because they are the most common benign liver tumor, the incidence of which ranges from 0.4% to 20% of the total population."
| PMC

reach
"Here, we report a novel truncating mutation in the ubiquitin-specific peptidase gene (USP53) causing low-gamma-GT (GGT) cholestasis."
| PMC

reach
"In this study, we aimed to characterize clinical findings and biological insights on a novel USP53 splice variant causing cholestasis phenotype and provided a review of the literature."
USP53 inhibits Cholestasis.
| 3
| 3

reach
"However, how USP53 deficiency contributes to cholestasis is obscure."

reach
"Collectively, the results converge into a model in which loss of the USP53 catalytic activity reported herein causes pediatric cholestasis (Fig. 3)."

reach
"USP53 deficiency leads to cholestasis, and may be accompanied by hearing impairment or hearing loss in severe cases."
RIPK1 affects USP53
| 10
| 10

sparser
"Targeting the USP53RIPK1 axis could be a potential strategy for the treatment of alcohol-associated myocardial damage."

sparser
"Our work elucidates the pathogenic role of the USP53RIPK1 signaling axis in EtOH-induced cardiomyopathy, providing a novel molecular target for therapeutic intervention."

sparser
"USP53 interacts with the intermediate domain of RIPK1 via its C-terminal region."

sparser
"Cotransfection of USP53 mutants and HA-tagged RIPK1 in HEK-293T cells showed that both the full length and the C terminus of USP53 could interact with RIPK1, but not the N terminus of USP53, which indicated that the C terminus of USP53 was essential for interacting with RIPK1 (Fig. xref J)."

sparser
"Subsequently, USP53 interacted with the intermediate domain of RIPK1 and removed K63-linked ubiquitination at lysine-377 (K377), facilitating RIPK1 phosphorylation and triggering downstream apoptotic and necroptotic pathways in cardiac cells."

sparser
"USP53 directly binds to RIPK1 and triggers its kinase activity by removing the K63-linked ubiquitin chain at the lysine-377 (K377) site, which in turn drives apoptosis and necroptosis, and exacerbates ACM."

sparser
"However, Co-IP assay revealed that the K377R mutation did not affect the interaction between RIPK1 and USP53 (Fig. xref G)."

sparser
"These results highlight the USP53RIPK1 signaling axis as a potential therapeutic target for mitigating ACM progression."

sparser
"These findings revealed the critical role of USP53RIPK1 interaction in driving alcoholic CM injury and ACM."

sparser
"Mechanistically, USP53 directly interacts with RIPK1 and activates RIPK1 kinase activity by disrupting K63-linked ubiquitination at K377, the major K63 ubiquitination site in human RIPK1 [ xref ]."
DDB2 affects USP53
2 | 2 5
2 | 2 5

sparser
"Interestingly, we also confirmed that USP53 interacts with DDB2 by co-immunoprecipitation ( xref )."

sparser
"Thus, the physiological relevance of USP53-DDB2 interactions is unclear."

No evidence text available

reach
"XREF_BIBR USP53 interacts with DDB2, but knockdown of USP53 has no effect on DDB2 stability."

No evidence text available

sparser
"For instance, USP9X influences apoptosis by targeting MCL-1 [ xref , xref ] or regulates TGFβ signaling via KDM4C [ xref ], while USP7 and USP24 target p53 [ xref , xref ], USP13 targets PTEN [ xref ], USP53 interacts with DNA damage binding protein 2 (DDB2) [ xref ], and USP28 modulates HIF-1α [ xref ]."

sparser
"Damage-specific DNA binding protein 2 (DDB2) is involved in nucleotide excision repair, which can repair DNA damage, and prevent gene mutation and tumorigenesis. xref Zou et al showed that knockdown of DDB2 expression in human lung cancer cells decreases the G2 phase and the repair efficiency of homologous recombination to increase the sensitivity of lung cancer cells to radiotherapy. xref Damage-specific DNA binding protein has been shown to interact with USP53, although the physiological relevance of USP53DDB2 interactions remains unclear. xref In this study, we knocked down USP53 to provide evidence that the relationship between USP53 and DDB2 increases the radiosensitivity of cervical squamous cell carcinoma."

reach
"Interestingly, we also confirmed that USP53 interacts with DDB2 by co-immunoprecipitation (XREF_FIG)."

sparser
"USP53 interacts with DDB2, but knockdown of USP53 has no effect on DDB2 stability."
ZMYND11 affects USP53
| 1 8
| 1 8

sparser
"These results suggested that USP53 interacted with ZMYND11 and intercepted its ubiquitination in breast cancer cells."

sparser
"Additionally, Meng X. et al. demonstrated that USP53 interacts with ZMYND11 to enhance its deubiquitination and stability, inhibiting breast cancer cell proliferation and inducing apoptosis [ xref ]."

reach
"Co-immunoprecipitation data suggested that USP53 interacted with zinc finger MYND-type containing 11 (ZMYND11), and catalyzed its deubiquitination and stabilization."

sparser
"Co-immunoprecipitation data suggested that USP53 interacted with zinc finger MYND-type containing 11 (ZMYND11), and catalyzed its deubiquitination and stabilization."

sparser
"USP53-ZMYND11 axis may be a good potential biomarker or therapeutic target for breast cancer, which can provide novel insights into the diagnosis, treatment and prognosis."

sparser
"USP53-ZMYND11 axis may be a potential breast cancer marker and therapeutic target."

sparser
"ZMYND11 was Associated with USP53 and Breast Cancer Prognosis."

sparser
"USP53 Interacted with ZMYND11 and Blocked its Ubiquitination."

sparser
"Given the potential interaction between USP53 and ZMYND11, we determined the ZMYND11 level after USP53 changes."
TJP2 affects USP53
1 | 2 6
1 | 2 5

sparser
"Interactions of USP53 and TJP2 were investigated by immunofluorescence and co-immunoprecipitation."

sparser
"USP53 interacts with TJP2."

sparser
"It has been suggested that USP53 may interact with TJP2 and regulate its function in the liver."

No evidence text available

reach
"Instead of binding with Ub, USP53 interacts with ZO-1 and ZO-2 as a part of the tight junction complex."

sparser
"Research in mice has demonstrated that USP53 interacts with TJP2 (ZO-2), contributing to the integrity of tight junctions (Figure xref )[ xref , xref ]."

reach
"USP53 interacts with the tight-junction constituent TJP2."

sparser
"USP53 interacts with the tight-junction constituent TJP2."
USP53 binds TJP1 and TJP2. 1 / 1
| 1

sparser
"Instead of binding with Ub, USP53 interacts with ZO-1 and ZO-2 as a part of the tight junction complex (Kazmierczak et al., xref )."
| 7

reach
"We hypothesized that USP53 may positively regulate the osteogenic differentiation of hBMSCs in vitro and that local delivery of AAV2-USP53 to calvarial defects would thus enhance bone formation."

reach
"USP53 has been found to promote osteogenic differentiation [3]."

reach
"These results suggested that knockdown of USP53 decreased the osteogenic differentiation of hBMSCs."

reach
"Overexpression of USP53 promoted the osteogenic differentiation of hBMSCs in vitro."

reach
"Thus, USP53 positively regulated the osteogenic differentiation of hBMSCs."

reach
"USP53 enhances osteogenic function and differentiation in human BMSCs by stabilizing key proteins associated with osteogenic differentiation and regulating the BMP signaling pathway."

reach
"In addition, USP53 overexpression increased the level of active beta-catenin and enhanced the osteogenic differentiation of hBMSCs."
| 1

reach
"Knockdown of USP53 inhibited the osteogenic differentiation of hBMSCs in vitro."
USP53 affects CTNNB1
1 | 6 1
USP53 activates CTNNB1.
| 3
USP53 activates CTNNB1. 3 / 3
| 3

reach
"Additionally, we confirmed that USP53 overexpression promoted osteogenesis in hBMSCs by activating the Wnt and beta-catenin signaling pathway in vitro and that USP53 bound with FBXO31 during the osteogenic differentiation of hBMSCs."

reach
"In vitro ubiquitination assays showed that beta-catenin degradation was significantly reduced by USP53 overexpression in a concentration dependent manner, whereas downregulation of USP53 promoted the degradation of beta-catenin."

reach
"Moreover, USP53 increased the half-life of active beta-catenin compared with that in the control group."
USP53 inhibits CTNNB1.
| 2
USP53 bound to FBXO31 inhibits CTNNB1. 1 / 1
| 1

reach
"Mass spectrometry showed that USP53 interacted with F-box only protein 31 (FBXO31) to promote proteasomal degradation of beta-catenin."
USP53 inhibits CTNNB1. 1 / 1
| 1

reach
"In vitro ubiquitination assays showed that beta-catenin degradation was significantly reduced by USP53 overexpression in a concentration dependent manner, whereas downregulation of USP53 promoted the degradation of beta-catenin."
USP53 binds CTNNB1.
1 | 1
| 1

sparser
"First, we examined the mechanism through which FBXO31 regulated the stability of β-catenin, a key mediator of the Wnt signaling pathway xref and bone formation during osteogenic differentiation xref , using co-IP and western blot assays with wild-type FBXO31 and myc-FBXO31ΔF. As shown in Fig. xref , FBXO31 specifically interacted with β-catenin, Skp1, and USP53."
1 |

No evidence text available
USP53 increases the amount of CTNNB1.
| 1
USP53 increases the amount of CTNNB1. 1 / 1
| 1

reach
"In addition, USP53 overexpression increased the level of active beta-catenin and enhanced the osteogenic differentiation of hBMSCs."
USP53 affects Neoplasms
| 7
USP53 inhibits Neoplasms.
| 4
| 4

reach
"Moreover, animal experiments demonstrated that USP53 overexpression inhibited tumor growth in nude mice [67]."

reach
"Overexpression of USP53 reduced tumor growth in vivo."

reach
"USP53 inhibited the proliferation and metastasis of ccRCC cells (786-O and Caki-1) via the NF-κB pathway in vitro, and the knockdown of USP53 promoted the growth of transplanted tumors in nude mice with ccRCC."

reach
"As shown in Fig. 3A–C, USP53 overexpression significantly decreased the growth rate and the tumor volume, which implied lower proliferative ability."
USP53 activates Neoplasms.
| 3
| 3

reach
"The overexpression of USP53 in TNBC promotes the deubiquitination of CRKL and tumor growth and metastasis in TNBC."

reach
"As shown, the knockdown of USP53 significantly reduced the proliferation of mouse mammary tumors (Figure 2m)."

reach
"In addition, USP53 overexpression significantly decreased the percentage of Ki-67+ proliferating cells and increased that of TUNEL + apoptotic cells in the tumor tissues compared to the control (Fig. 3G–I)."
USP53 affects HYCC1
| 7
USP53 inhibits HYCC1.
| 4
USP53 inhibits HYCC1. 4 / 4
| 4

reach
"Wound-healing and transwell assays showed that the overexpressed USP53 significantly inhibited the migration (Fig. 2D–G) and invasion (Fig. 2H, I) of HCC cells in vitro."

reach
"Taken together, USP53 inhibited HCC growth in vivo by impairing cell proliferation and enhancing cell apoptosis."

reach
"Taken together, USP53 inhibited the proliferation and migration of HCC cells by inducing the blocking at G1/S phases and increasing cell apoptosis."

reach
"Overexpression of USP53 inhibited the proliferation and migration of HCC cells in vitro."
USP53 activates HYCC1.
| 3
USP53 activates HYCC1. 3 / 3
| 3

reach
"Furthermore, forced expression of USP53 inhibited the proliferation, migration and invasion, and induced apoptosis in HCC cell lines both in vitro and in vivo."

reach
"Furthermore, the ectopic expression of USP53 inhibited the proliferation, migration and invasion, and induced the apoptosis of HCC cells."

reach
"USP53 enhanced the apoptosis of HCC cells via deubiquitination of CYCS, and had a potential as a promising novel therapeutic target for HCC."
USP53 affects ccRCC
| 6
USP53 inhibits ccRCC.
| 5
USP53 inhibits ccRCC. 5 / 5
| 5

reach
"In summary, USP53 inhibits the p65 and p50 complex by deubiquitinating IκBα, and further inhibits the activity of the NF‐κB pathway.3.7 Knockdown USP53 promotes the growth of ccRCC in vivo ."

reach
"Moreover, USP53 knockdown promoted the ability of clone formation of ccRCC in vivo."

reach
"Then, we performed immunohistochemical staining on the tissues of patients with renal clear cell carcinoma and found that the expression of USP53 in tumor tissues was significantly lower than paracancerous tissues (Figure 1F).3.2 Overexpression USP53 inhibits the growth and proliferation of ccRCC."

reach
"BrdU cell proliferation assay was also used to test the proliferative ability of cells, and the proliferation of USP53 overexpression cells was inhibited compared with control (Figure 2G,H).3.3 Knockdown USP53 promotes the growth and proliferation of ccRCC."

reach
"EDU cell proliferation imaging assay and BrdU cell proliferation assay also showed that the proliferation of ccRCC after USP53 knockdown was promoted compare with shGFP (Figure 3E–H).3.4 Overexpression USP53 inhibits migration and invasion of ccRCC."
USP53 activates ccRCC.
| 1
USP53 activates ccRCC. 1 / 1
| 1

reach
"The ability of cell migration and invasion was tested via Transwell assays, we found fewer migrated cells on the Transwell chamber surface compared to the controls after overexpression USP53 (Figure 4C,D), the quantitative results are at the bottom of the picture.3.5 Knockdown USP53 promotes migration and invasion of ccRCC."
USP53 affects NFASC
| 6
USP53 inhibits NFASC.
| 4
USP53 inhibits NFASC. 4 / 4
| 4

reach
"Here, we can guess that USP53 may inhibit the NF‐κB pathway by inhibiting the degradation of IκBα."

reach
"We described a new mechanism by which USP53 inhibits ccRCC survival via the downregulation of the NF‐κB signaling pathway."

reach
"USP53 (Ubiquitin specific peptidase 53) inhibits the initiation and progression of renal cell carcinoma by inhibiting activation of the nuclear factor κB (NF‐κB) pathway; it promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51‐AKT1 signaling [52, 53]."

reach
"Furthermore, USP53 inhibited the progression of clear cell renal cell carcinoma by suppressing the nuclear factor κB (NF‐κB) pathway [9]."
USP53 activates NFASC.
| 2
USP53 activates NFASC. 2 / 2
| 2

reach
"34 , 36 USP53 mediate NF‐κB signaling pathway is also used for verification in other tumor contexts."

reach
"The regulation mechanism of USP53 mediated NF‐κB signaling pathway still needs to be explored then ascertain the functional effects of USP53 in ccRCC."
USP53 affects Flag
| 6
| 6

sparser
"In order to figure out why USP53 will affect the expression of IκBα, we transfected Myc‐ub, HA‐IκBα, and FlagUSP53 into 293 cells, and then tested the effect of USP53 on the ubiquitination of IκBα by co‐immunoprecipitation and WB experiments."

sparser
"We mutated lysine (K) to arginine (R) to generate point mutants of RIPK1, including HA-RIPK1-K302R, HA-RIPK1-K306R, HA-RIPK1-K316R, and HA-RIPK1-K377R. By cotransfection of Flag-USP53, Myc-Ub, and each RIPK1 mutant in HEK-293T cells, we observed that the K377R mutation effectively inhibited the USP53-induced RIPK1 deubiquitination, whereas K302R, K306R, and K316R did not affect this process (Fig. xref G)."

sparser
"The results showed direct interaction between HA-RIPK1 and Flag-USP53 (Fig. xref E and F)."

sparser
"Similar results were found in human embryonic kidney (HEK)-293T cells transfected with hemagglutinin (HA)-RIPK1 and Flag-USP53, which showed colocalization of HA-RIPK1 and Flag-USP53 in cytoplasm (Fig. xref D)."

sparser
"By cotransfection of HA-RIPK1 with either Flag-USP53 or Flag-USP53-C41S in HEK-293T cells, we found that catalytic site-mutated USP53-C41S was unable to inhibit the ubiquitination of RIPK1 (Fig. xref B)."

sparser
"By cotransfection of Flag-USP53 and RIPK1 mutants in AC16 cells, we observed that overexpression of USP53 significantly augmented EtOH-induced RIPK1 autophosphorylation, while K377R mutation effectively blocked the up-regulation of pRIPK1 Ser 166 mediated by USP53 (Fig. xref H and Fig. xref H)."
USP53 affects FKBP4
| 6
USP53 deubiquitinates FKBP4. 6 / 6
| 6

reach
"Besides, USP53 could also induce cell apoptosis in lung adenocarcinoma cells through deubiquitinating FKBP51 [8]."

reach
"Lung adenocarcinoma cells are regulated by USP53, which deubiquitinates FKBP51, dephosphorylates AKT1, and controls glycolysis and apoptosis [10]."

reach
"Mechanistically, USP53 deubiquitinates FKBP51, which in turn dephosphorylates AKT1, and ultimately inhibits tumor growth in lung adenocarcinoma."

reach
"USP53 is lowly expressed in lung adenocarcinoma, and USP53 deubiquitinates FKBP51, which thereby inhibits tumor growth in lung adenocarcinoma (72).2.5 Ubiquitination enzyme and the treatment of LC."

reach
"As a tumour suppressor, USP53 can deubiquitinate FK506-binding protein 51 (FKBP51) to dephosphorylate AKT1 and inactivate downstream signalling pathways, thereby inhibiting the progression of LUAD (98)."

reach
"USP53 deubiquitinated FKBP51 in lung adenocarcinoma cells (H1975 and HCC827), which, in turn, dephosphorylated AKT1, inducing cell apoptosis and inhibiting glycolysis through this signaling pathway."
USP53 affects EIF4A3
| 6
| 6

sparser
"In this study, we found that EIF4A3 could interact with USP53 to stabilize its mRNA expression."

sparser
"ENCORI software was used to analyze the upstream regulatory genes of USP53, and the results showed that USP53 interacted with EIF4A3 (Fig.  xref A)."

sparser
"Here, the ENCORI website predicted that USP53 interacted with EIF4A3."

sparser
"USP53 level was enriched by anti-EIF4A3, indicating that EIF4A3 bound to the USP53 protein (Fig.  xref B)."

sparser
"The above results suggested that EIF4A3 interacted with USP53 to stabilize its mRNA expression."

sparser
"EIF4A3 interacted with USP53."
Flag affects USP53
| 6
| 6

sparser
"In order to figure out why USP53 will affect the expression of IκBα, we transfected Myc‐ub, HA‐IκBα, and FlagUSP53 into 293 cells, and then tested the effect of USP53 on the ubiquitination of IκBα by co‐immunoprecipitation and WB experiments."

sparser
"We mutated lysine (K) to arginine (R) to generate point mutants of RIPK1, including HA-RIPK1-K302R, HA-RIPK1-K306R, HA-RIPK1-K316R, and HA-RIPK1-K377R. By cotransfection of Flag-USP53, Myc-Ub, and each RIPK1 mutant in HEK-293T cells, we observed that the K377R mutation effectively inhibited the USP53-induced RIPK1 deubiquitination, whereas K302R, K306R, and K316R did not affect this process (Fig. xref G)."

sparser
"The results showed direct interaction between HA-RIPK1 and Flag-USP53 (Fig. xref E and F)."

sparser
"Similar results were found in human embryonic kidney (HEK)-293T cells transfected with hemagglutinin (HA)-RIPK1 and Flag-USP53, which showed colocalization of HA-RIPK1 and Flag-USP53 in cytoplasm (Fig. xref D)."

sparser
"By cotransfection of HA-RIPK1 with either Flag-USP53 or Flag-USP53-C41S in HEK-293T cells, we found that catalytic site-mutated USP53-C41S was unable to inhibit the ubiquitination of RIPK1 (Fig. xref B)."

sparser
"By cotransfection of Flag-USP53 and RIPK1 mutants in AC16 cells, we observed that overexpression of USP53 significantly augmented EtOH-induced RIPK1 autophosphorylation, while K377R mutation effectively blocked the up-regulation of pRIPK1 Ser 166 mediated by USP53 (Fig. xref H and Fig. xref H)."
EIF4A3 affects USP53
| 6
| 6

sparser
"In this study, we found that EIF4A3 could interact with USP53 to stabilize its mRNA expression."

sparser
"ENCORI software was used to analyze the upstream regulatory genes of USP53, and the results showed that USP53 interacted with EIF4A3 (Fig.  xref A)."

sparser
"Here, the ENCORI website predicted that USP53 interacted with EIF4A3."

sparser
"USP53 level was enriched by anti-EIF4A3, indicating that EIF4A3 bound to the USP53 protein (Fig.  xref B)."

sparser
"The above results suggested that EIF4A3 interacted with USP53 to stabilize its mRNA expression."

sparser
"EIF4A3 interacted with USP53."
Bisphenol A affects USP53
5 |
Bisphenol A increases the amount of USP53.
2 |
Bisphenol A increases the amount of USP53. 2 / 2
2 |

No evidence text available

No evidence text available
Bisphenol A methylates USP53.
1 |
1 |

No evidence text available
Bisphenol A demethylates USP53.
1 |
Bisphenol A demethylates USP53. 1 / 1
1 |

No evidence text available
Bisphenol A decreases the amount of USP53.
1 |
Bisphenol A decreases the amount of USP53. 1 / 1
1 |

No evidence text available
| 1 1 3
| 1 1 3

eidos
"USP53 also inhibits glycolysis , oxidative metabolism , and mitochondrial dynamics ."

trips
"USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51-AKT1 signaling."

reach
"USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51-AKT1 signaling."

reach
"In addition, USP53 also suppressed glycolysis, oxidative metabolism, and mitochondrial dynamics."

reach
"USP53 also inhibits glycolysis, oxidative metabolism, and mitochondrial dynamics."
USP53 affects SR-A
| 5
USP53 binds SR-A. 5 / 5
| 5

sparser
"To explore whether USP53 interacts with SR-A, co-immunoprecipitation (Co-IP) and immunoblotting (IB) experiments were performed using HASMCs or HEK293T. The results showed that USP53 and SR-A efficiently co-immunoprecipitated (Figure xref E, 7F)."

sparser
"These results demonstrate that USP53 interacts with SR-A, which can be enhanced by endothelial DKK1."

sparser
"Furthermore, Co-IP experiments confirmed endogenous and exogenous interactions between USP53 and SR-A. These results suggest that USP53 may represent an intermediate molecular mechanism that mediates DKK1 to regulate the expression of SR-A in SMCs and influence the formation of foam cells."

sparser
"Additionally, the interaction between USP53 and SR-A in HASMCs was enhanced by exogenous rDKK1 treatment (Figure xref G) or co-culturing with ECs overexpressing DKK1 (Lenti-GFP-DKK1 EC, Figure xref H)."

sparser
"USP53 interacts with SR-A and regulates K48-linked polyubiquitination in SMCs, which may be enhanced by endothelial DKK1."
MSR1 affects USP53
| 5
MSR1 binds USP53.
| 4
| 3

reach
"Furthermore, Co-IP experiments confirmed endogenous and exogenous interactions between USP53 and SR-A."

reach
"This is consistent with our finding that USP53 interacts with, and deubiquitinates SR-A, thereby stabilizing SR-A and promoting the formation of SMC-derived foam cells."

reach
"Additionally, the interaction between USP53 and SR-A in HASMCs was enhanced by exogenous rDKK1 treatment (Figure 7G) or co-culturing with ECs overexpressing DKK1 (Lenti-GFP-DKK1 EC, Figure 7H)."
USP53 binds MSR1 and USP domain. 1 / 1
| 1

reach
"RNA sequencing revealed that DKK1-induced SR-A upregulation in SMCs is dependent on Ubiquitin-specific Protease 53 (USP53), which bound to SR-A via its USP domain and cysteine at position 41, exerting deubiquitination to maintain the stability of the SR-A protein by removing the K48 ubiquitin chain and preventing proteasomal pathway degradation, thereby mediating the effect of DKK1 on lipid uptake in SMCs."
MSR1 activates USP53.
| 1
MSR1 activates USP53. 1 / 1
| 1

reach
"In addition, SR-A knockdown reduced the stimulatory effect of USP53 on SMC-derived foam cell formation (Figure 6M, 6N)."
H3K27 affects USP53
| 5
H3K27 activates USP53.
| 3
H3K27 activates USP53. 3 / 3
| 3

reach
"USP53 activated by H3K27 acetylation regulates cell viability, apoptosis, and metabolism in esophageal carcinoma via the AMPK signaling pathway."

reach
"This study finally revealed that USP53 was activated by H3K27 acetylation in a variety of ESCA cells, whereafter suppressing proliferation, promoting apoptosis, and inducing mitochondrial damage by inactivating the AMPK pathway.Radiotherapy is one of the main treatments for ESCA, but some patients are susceptible to radiotherapy resistance."

reach
"Cheng et al. [60] reported that USP53 inhibited the proliferation and growth of esophageal carcinoma cells in vitro and in vivo, and that USP53 activation by H3K27 acetylation modulates cell viability via the AMPK signaling pathway."
H3K27 increases the amount of USP53.
| 2
Acetylated H3K27 increases the amount of USP53. 2 / 2
| 2

reach
"H3K27 acetylation increases USP53 expression by binding to its promoter region."

reach
"USP53 expression in ESCA can be increased by H3K27 acetylation combined with its promoter region."
CREB affects USP53
| 5
CREB activates USP53.
| 3
CREB activates USP53. 3 / 3
| 3

sparser
"Our data (Fig.  xref C–E) have demonstrated the PTH-induced CREB activation of the Usp53 promoter."

sparser
"We then assessed the JUN-CREB activation of the Usp53 cloned fragment in Naca -knockdown cells."

sparser
"The transcriptional activation of the Usp53 promoter by CREB alone, CREB/JUN together or NACA/JUN/CREB combined was completely abolished following the overexpression of 100 ng of DN-PKA expression vector (Fig.  xref F)."
CREB binds USP53.
| 2
| 2

sparser
"As expected, CREB specifically bound to the USP53 promoter, which could be enhanced by rDKK1 ( xref E)."

sparser
"Moreover, DKK1 regulates the transcription of USP53 by facilitating the binding of transcription factor CREB to the USP53 promoter."
ATF3 affects USP53
| 4 1
ATF3 inhibits USP53.
| 2 1
ATF3 inhibits USP53. 3 / 3
| 2 1

sparser
"Consequently, ATF3 might transcriptionally inactivate USP53 to repress adipocyte adipogenesis and downregulate the RhoA/ROCK pathway."

reach
"ATF3 suppresses 3T3-L1 adipocyte adipogenesis by transcriptionally repressing USP53."

reach
"Consequently, ATF3 might transcriptionally inactivate USP53 to repress adipocyte adipogenesis and downregulate the RhoA/ROCK pathway."
ATF3 increases the amount of USP53.
| 1
ATF3 increases the amount of USP53. 1 / 1
| 1

reach
"ATF3 suppressed the transcription of USP53 as a transcription factor and lowered USP53 expression."
ATF3 decreases the amount of USP53.
| 1
ATF3 decreases the amount of USP53. 1 / 1
| 1

reach
"ATF3 suppressed the transcription of USP53 as a transcription factor and lowered USP53 expression."

reach
"Additionally, the knockdown of USP53 suppressed proliferation, EMT, and metastasis and enhanced the paclitaxel response of TNBC cells."

reach
"Because upregulation of USP53 promoted proliferation, migration, invasion, and EMT in TNBC, we investigated whether this was due to the regulation of CRKL by USP53."

reach
"Taken together, USP53 promotes metastasis and EMT in TNBC."

reach
"Functionally, USP53 promotes TNBC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT)."
USP53 affects TNFSF11
| 4
USP53 decreases the amount of TNFSF11.
| 3
USP53 decreases the amount of TNFSF11. 3 / 3
| 3

reach
"Usp53 null mice displayed increased serum RANKL levels and Usp53 deficient osteoblasts and bone marrow adipocytes have increased expression of Rankl."

reach
"Loss of USP53 up-regulates RANKL expression, promotes the cytogenesis and functional activity of osteoclasts, and triggers osteodestructive diseases."

reach
"It has been found that USP53 deficiency upregulates RANKL expression in osteoblasts and bone marrow adipocytes to support osteoclast production through the VDR-SMAD3 pathway and promotes bone marrow adipogenesis [61]."
USP53 activates TNFSF11.
| 1
USP53 activates TNFSF11. 1 / 1
| 1

reach
"In addition, USP53 acting on the vitamin D-receptor-SMAD3 pathway increases RANKL-dependent osteoclastogenesis through osteoblasts (71)."
USP53 affects TNBC
| 4
USP53 activates TNBC. 4 / 4
| 4

reach
"Functionally, USP53 promotes TNBC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT)."

reach
"USP53 Promotes TNBC Cell Metastasis."

reach
"In this study, we found that USP53 promoted the growth and metastasis of TNBC."

reach
"Overexpression of USP53 accelerated TNBC cell proliferation (Figure 2f,h)."
USP53 affects NFKB1
| 1 3
USP53 inhibits NFKB1. 4 / 4
| 1 3

sparser
"In summary, USP53 inhibits the p65 and p50 complex by deubiquitinating IκBα, and further inhibits the activity of the NF‐κB pathway."

sparser
"USP53 can inhibit the complex of p50 and p65 by deubiquitinizing IκBα, thereby inhibiting the activity of the NF-κB pathway and ultimately inhibiting the proliferation and metastasis of ccRCC [ xref ]."

sparser
"USP53 inhibits the p65 and p50 complex by deubiquitinating IκBα, and further inhibits the activity of the NF‐κB pathway."

reach
"USP53 can inhibit the complex of p50 and p65 by deubiquitinizing IκBα, thereby inhibiting the activity of the NF-κB pathway and ultimately inhibiting the proliferation and metastasis of ccRCC [92]."
USP53 affects Deafness
| 4
USP53 activates Deafness.
| 3
| 2

reach
"Mutations in the USP53 gene can cause cholestasis and deafness and may also be a potential cause of schizophrenia."

reach
"USP53 encodes a protein of uncertain function and USP53 deficiency causes deafness in mice."
| PMC
Mutated USP53 activates Deafness. 1 / 1
| 1

reach
"They can modulate barrier properties and mechanical stability of tight junctions.914 Therefore, USP53 mutation underlies a mouse deafness model."
USP53 inhibits Deafness.
| 1
| 1

reach
"USP53 encodes a protein of uncertain function and USP53 deficiency causes deafness in mice."
| PMC

reach
"USP53 (Ubiquitin specific peptidase 53) inhibits the initiation and progression of renal cell carcinoma by inhibiting activation of the nuclear factor κB (NF‐κB) pathway; it promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51‐AKT1 signaling [52, 53]."

reach
"Furthermore, USP53 inhibited the progression of clear cell renal cell carcinoma by suppressing the nuclear factor κB (NF‐κB) pathway [9]."

reach
"Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-kappaB pathway inactivation."

reach
"In addition, USP53 also inhibited the proliferation and migration of clear renal cell carcinoma cells by inactivating the NF-κB pathway [9]."
Methylmercury chloride decreases the amount of USP53. 3 / 3
3 |

No evidence text available

No evidence text available

No evidence text available
| 1 2

reach
"In addition, USP53 also suppressed glycolysis, oxidative metabolism, and mitochondrial dynamics."

eidos
"USP53 also inhibits glycolysis , oxidative metabolism , and mitochondrial dynamics ."

reach
"USP53 also inhibits glycolysis, oxidative metabolism, and mitochondrial dynamics."
USP53 affects cell growth
| 3
USP53 inhibits cell growth.
| 2
| 2

reach
"Our study reveals that USP53 is activated by H3K27 acetylation and suppresses ESCA progression by regulating cell growth and metabolism."

reach
"USP53 gene has been associated with some models of tumorigenesis:–In clear cell renal cell carcinoma inhibits the occurrence and development of cancer through NF-κB pathway inactivation [93];–In cervical squamous cell carcinoma correlated with the sensitivity to radiotherapy [94];–In oesophagal carcinoma, USP53 suppresses cancer progression by regulating cell growth and metabolism [95];–In lung adenocarcinoma, USP53 regulates cell apoptosis and glycolysis through the AKT1 pathway acting as a tumour suppressor [96]."
USP53 activates cell growth.
| 1
| 1

reach
"To further determine if USP53 mediate cell growth and migration inhibition through NF‐κB signaling pathway, we analyzed the phosphorylation of IKKβ, P65, and IκBα in USP53 overexpression and knockdown cells via immunoblot assays."
USP53 affects SYT1
| 3
USP53 leads to the dephosphorylation of SYT1. 3 / 3
| 3

reach
"USP53 overexpression decreased the phosphorylation of IKKbeta and P65 in both Caki-1 and 786-O cells, and the expression of IkappaBalpha was increased."

reach
"The result showed that USP53 overexpression decreased the phosphorylation of IKKβ and P65 in both Caki‐1 and 786‐O cells."

reach
"USP53 overexpression decreased the phosphorylation of IKKβ and P65 and increase the expression of IκBα."
USP53 affects NFKBIA
1 | 2
USP53 deubiquitinates NFKBIA.
1 | 1
USP53 leads to the deubiquitination of NFKBIA. 2 / 2
1 | 1

"CONCLUSION: In summary, our data indicate that <span class="match term0">USP53</span> inhibits the inactivation of the NF-kappaB pathway by reducing the ubiquitination of IkappaBalpha to further inhibit ccRCC proliferation and metastasis"

reach
"As the expression of USP53 increases, the protein expression of IkappaBalpha was also gradually increased and USP53 reduced the ubiquitination of IkappaBalpha."
USP53 ubiquitinates NFKBIA.
| 1
USP53 leads to the ubiquitination of NFKBIA. 1 / 1
| 1

reach
"In summary, our data indicate that USP53 inhibits the inactivation of the NF-kappaB pathway by reducing the ubiquitination of IkappaBalpha to further inhibit ccRCC proliferation and metastasis."
USP53 affects NACA
| 1 2
USP53 binds NACA.
| 2
| 2

sparser
"The ChIP-Seq data indicated the binding of NACA to the proximal region of the Usp53 promoter."

sparser
"Binding of NACA to the proximal promoter of Usp53 was confirmed by ChIP-PCR on MC3T3-E1 cells stimulated with PTH (1–34) or vehicle under the same conditions (Fig.  xref B)."
USP53 activates NACA.
| 1
USP53 activates NACA. 1 / 1
| 1

reach
"Using ChIP-Seq against NACA in parallel with RNA sequencing, we report the identification of Ubiquitin Specific Peptidase 53 (Usp53) as a target gene of PTH activated NACA in osteoblasts."
USP53 affects CRK
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
USP53 affects CDH1
1 | 2
USP53 increases the amount of CDH1.
| 1
USP53 increases the amount of CDH1. 1 / 1
| 1

reach
"Knockdown of USP53 decreased Snail1 and N-cadherin expression levels and increased E-cadherin expression levels in MDA-MB-231 cells (Figure 3e)."
USP53 decreases the amount of CDH1.
| 1
USP53 decreases the amount of CDH1. 1 / 1
| 1

reach
"Knockdown of USP53 decreased Snail1 and N-cadherin expression levels and increased E-cadherin expression levels in MDA-MB-231 cells (Figure 3e)."
USP53 binds CDH1.
1 |
1 |

No evidence text available
CRK affects USP53
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
2,3,7,8-tetrachlorodibenzodioxine increases the amount of USP53.
2 |
2 |

No evidence text available

No evidence text available
2,3,7,8-tetrachlorodibenzodioxine decreases the amount of USP53.
1 |
1 |

No evidence text available
3 |
(+)-JQ1 compound increases the amount of USP53. 3 / 3
3 |

No evidence text available

No evidence text available

No evidence text available
4,4'-sulfonyldiphenol increases the amount of USP53. 3 / 3
3 |

No evidence text available

No evidence text available

No evidence text available
2 |
Thioacetamide increases the amount of USP53. 2 / 2
2 |

No evidence text available

No evidence text available
2 |
Sodium arsenite decreases the amount of USP53. 2 / 2
2 |

No evidence text available

No evidence text available
RDKK1 affects USP53
| 2
RDKK1 activates USP53. 2 / 2
| 2

reach
"Furthermore, the upregulation of USP53 induced by rDKK1 was markedly reversed by CREB siRNA (Figure S11D)."

reach
"These findings were validated by chromatin immunoprecipitation (ChIP) assay.As expected, CREB specifically bound to the USP53 promoter, which could be enhanced by rDKK1 (Figure S11E)."
2 |
Progesterone increases the amount of USP53.
1 |
Progesterone increases the amount of USP53. 1 / 1
1 |

No evidence text available
Progesterone decreases the amount of USP53.
1 |
Progesterone decreases the amount of USP53. 1 / 1
1 |

No evidence text available
Paracetamol affects USP53
2 |
Paracetamol increases the amount of USP53. 2 / 2
2 |

No evidence text available

No evidence text available
2 |
Hsa-miR-16-5p decreases the amount of USP53. 2 / 2
2 |

No evidence text available

No evidence text available
Folic acid affects USP53
2 |
Folic acid increases the amount of USP53.
1 |
Folic acid increases the amount of USP53. 1 / 1
1 |

No evidence text available
Folic acid demethylates USP53.
1 |
Folic acid demethylates USP53. 1 / 1
1 |

No evidence text available
Ethanol affects USP53
2 |
Ethanol increases the amount of USP53. 2 / 2
2 |

No evidence text available

No evidence text available
2 |
Dexamethasone increases the amount of USP53. 2 / 2
2 |

No evidence text available

No evidence text available
Cisplatin affects USP53
2 |
Cisplatin increases the amount of USP53.
1 |
Cisplatin increases the amount of USP53. 1 / 1
1 |

No evidence text available
Cisplatin decreases the amount of USP53.
1 |
Cisplatin decreases the amount of USP53. 1 / 1
1 |

No evidence text available
Cadmium dichloride increases the amount of USP53. 2 / 2
2 |

No evidence text available

No evidence text available
Bisphenol F affects USP53
2 |
Bisphenol F increases the amount of USP53. 2 / 2
2 |

No evidence text available

No evidence text available
Abrine affects USP53
2 |
Abrine increases the amount of USP53.
1 |
Abrine increases the amount of USP53. 1 / 1
1 |

No evidence text available
Abrine decreases the amount of USP53.
1 |
Abrine decreases the amount of USP53. 1 / 1
1 |

No evidence text available
ZEB1 affects USP53
2 |
2 |

No evidence text available

No evidence text available
| 2

reach
"USP53 gene has been associated with some models of tumorigenesis:–In clear cell renal cell carcinoma inhibits the occurrence and development of cancer through NF-κB pathway inactivation [93];–In cervical squamous cell carcinoma correlated with the sensitivity to radiotherapy [94];–In oesophagal carcinoma, USP53 suppresses cancer progression by regulating cell growth and metabolism [95];–In lung adenocarcinoma, USP53 regulates cell apoptosis and glycolysis through the AKT1 pathway acting as a tumour suppressor [96]."

reach
"Our study reveals that USP53 is activated by H3K27 acetylation and suppresses ESCA progression by regulating cell growth and metabolism."
USP53 affects ZEB1
2 |
2 |

No evidence text available

No evidence text available
USP53 affects TRIM25
2 |
2 |

No evidence text available

No evidence text available
USP53 affects TRAF2
1 1 |
1 1 |

No evidence text available

No evidence text available
USP53 affects TJP1
| 1 1
USP53 binds TJP1 and TJP2. 1 / 1
| 1

sparser
"Instead of binding with Ub, USP53 interacts with ZO-1 and ZO-2 as a part of the tight junction complex (Kazmierczak et al., xref )."
| 1

reach
"Instead of binding with Ub, USP53 interacts with ZO-1 and ZO-2 as a part of the tight junction complex."
USP53 affects SLPI
| 2
USP53 activates SLPI. 2 / 2
| 2

reach
"Additionally, knockdown of USP53 decreased ALP and Alizarin Red S staining intensity as well as ALP activity."

reach
"Overexpression of USP53 enhanced ALP and Alizarin red S staining intensity as well as ALP activity."
USP53 affects S
2 |
S binds USP53. 1 / 1
1 |

No evidence text available
S binds USP53. 1 / 1
1 |

No evidence text available
USP53 affects RIPK3
| 2
| 2

sparser
"Given that RIPK3 is also a central mediator of necroptosis and is known to undergo ubiquitin modification, we performed Co-IP assays to investigate whether USP53 directly interacts with RIPK3."

sparser
"The results did not show detectable interaction between USP53 and RIPK3 in AC16 cells, either with or without EtOH treatment."
USP53 affects Neuralgia
| 2
| 2

reach
"In summary, this study revealed that USP53 exacerbated CCI‑induced neuropathic pain, potentially via regulation of the FKBP51/RhoA/ROCK pathway."

reach
"Their study demonstrated that USP53 aggravated chronic compressive injury-induced neuropathic pain by activating the FKBP51/RhoA/ROCK signaling pathway.José et al. identified a variant in USP53 (p.Cys228Arg) as an underlying cause of schizophrenia [66]."
USP53 affects NOTCH2
1 | 1
1 | 1

sparser
"In vitro experiments demonstrated that protein-protein interaction existed between USP53 and NOTCH2 and that the inhibition of USP53 prevented amyloid-beta (Aβ)-induced deubiquitination of NOTCH2."

No evidence text available
USP53 affects Mice
| 2
USP53 inhibits Mice.
| 1
USP53 inhibits Mice. 1 / 1
| 1

reach
"USP53 encodes a protein of uncertain function and USP53 deficiency causes deafness in mice."
| PMC
USP53 activates Mice.
| 1
USP53 activates Mice. 1 / 1
| 1

reach
"USP53 encodes a protein of uncertain function and USP53 deficiency causes deafness in mice."
| PMC
USP53 affects IKK_complex
| 2
USP53 leads to the dephosphorylation of IKK_complex. 2 / 2
| 2

reach
"USP53 overexpression decreased the phosphorylation of IKKβ and P65 and increase the expression of IκBα."

reach
"The result showed that USP53 overexpression decreased the phosphorylation of IKKβ and P65 in both Caki‐1 and 786‐O cells."
USP53 affects GGT1
| 2
USP53 activates GGT1. 2 / 2
| 2

reach
"Here, we report a novel truncating mutation in the ubiquitin-specific peptidase gene (USP53) causing low-gamma-GT (GGT) cholestasis."
| PMC

reach
"Here, we report a novel truncating mutation in the ubiquitin-specific peptidase gene ( USP53 ) causing low-γ-GT (GGT) cholestasis."
USP53 affects FKBP5
2 |
2 |

No evidence text available

No evidence text available
USP53 affects EZH2
2 |
2 |

No evidence text available

No evidence text available
USP53 affects CREB
| 2
| 2

sparser
"As expected, CREB specifically bound to the USP53 promoter, which could be enhanced by rDKK1 ( xref E)."

sparser
"Moreover, DKK1 regulates the transcription of USP53 by facilitating the binding of transcription factor CREB to the USP53 promoter."
USP53 affects ATP8B1
| 2
USP53 activates ATP8B1. 2 / 2
| 2

reach
"PFIC is caused by mutations in ATP8B1, ABCB11, ABCB4, TJP2, NR1H4, SLC51A, USP53, KIF12, ZFYVE19, and MYO5B genes depending on its type."

reach
"A mutation in the USP53 gene is known to cause BRIC-like cholestasis with normal serum gamma-glutamyltransferase (GGT) levels."
USP53 affects AKT1
| 1 1
USP53 dephosphorylates AKT1. 2 / 2
| 1 1

sparser
"USP53 dephosphorylated AKT1 by deubiquitinating FKBP51, which in turn facilitated apoptosis and suppressed glycolysis in lung adenocarcinoma xref ."

reach
"Lung adenocarcinoma cells are regulated by USP53, which deubiquitinates FKBP51, dephosphorylates AKT1, and controls glycolysis and apoptosis [10]."
TRIM25 affects USP53
2 |
2 |

No evidence text available

No evidence text available
TRAF2 affects USP53
1 1 |
1 1 |

No evidence text available

No evidence text available
TJP1 affects USP53
| 1 1
USP53 binds TJP1 and TJP2. 1 / 1
| 1

sparser
"Instead of binding with Ub, USP53 interacts with ZO-1 and ZO-2 as a part of the tight junction complex (Kazmierczak et al., xref )."
| 1

reach
"Instead of binding with Ub, USP53 interacts with ZO-1 and ZO-2 as a part of the tight junction complex."
S affects USP53
2 |
S binds USP53. 1 / 1
1 |

No evidence text available
S binds USP53. 1 / 1
1 |

No evidence text available
RIPK3 affects USP53
| 2
| 2

sparser
"Given that RIPK3 is also a central mediator of necroptosis and is known to undergo ubiquitin modification, we performed Co-IP assays to investigate whether USP53 directly interacts with RIPK3."

sparser
"The results did not show detectable interaction between USP53 and RIPK3 in AC16 cells, either with or without EtOH treatment."
NOTCH2 affects USP53
1 | 1
1 | 1

sparser
"In vitro experiments demonstrated that protein-protein interaction existed between USP53 and NOTCH2 and that the inhibition of USP53 prevented amyloid-beta (Aβ)-induced deubiquitination of NOTCH2."

No evidence text available
NACA affects USP53
| 2
| 2

sparser
"The ChIP-Seq data indicated the binding of NACA to the proximal region of the Usp53 promoter."

sparser
"Binding of NACA to the proximal promoter of Usp53 was confirmed by ChIP-PCR on MC3T3-E1 cells stimulated with PTH (1–34) or vehicle under the same conditions (Fig.  xref B)."
H3K27 acetylation affects USP53
| 2
H3K27 acetylation activates USP53. 2 / 2
| 2

eidos
"H3K27 acetylation increases USP53 expression by binding to its promoter region ."

eidos
"Our study reveals that USP53 is activated by H3K27 acetylation and suppresses ESCA progression by regulating cell growth and metabolism ."
FKBP5 affects USP53
2 |
2 |

No evidence text available

No evidence text available
EZH2 affects USP53
2 |
2 |

No evidence text available

No evidence text available
DKK1 affects USP53
| 2
DKK1 inhibits USP53.
| 1
DKK1 inhibits USP53. 1 / 1
| 1

reach
"DKK1 inhibits proteasomal degradation of SR-A by upregulating USP53."
DKK1 activates USP53.
| 1
DKK1 activates USP53. 1 / 1
| 1

reach
"In addition, by using co-culture system, we found that knockdown of endothelial DKK1 inhibited the LowSS-induced upregulation of USP53 in co-cultured SMCs (Figure S9J)."
CTNNB1 affects USP53
1 | 1
| 1

sparser
"First, we examined the mechanism through which FBXO31 regulated the stability of β-catenin, a key mediator of the Wnt signaling pathway xref and bone formation during osteogenic differentiation xref , using co-IP and western blot assays with wild-type FBXO31 and myc-FBXO31ΔF. As shown in Fig. xref , FBXO31 specifically interacted with β-catenin, Skp1, and USP53."
1 |

No evidence text available
Vorinostat affects USP53
1 |
Vorinostat increases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Valproic acid increases the amount of USP53. 1 / 1
1 |

No evidence text available
Urethane affects USP53
1 |
Urethane increases the amount of USP53. 1 / 1
1 |

No evidence text available

No evidence text available
Triptonide affects USP53
1 |
Triptonide increases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Trichostatin A increases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
1 |

No evidence text available
Thiram affects USP53
1 |
Thiram increases the amount of USP53. 1 / 1
1 |

No evidence text available
Tetrachloromethane increases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Testosterone decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Silicon dioxide decreases the amount of USP53. 1 / 1
1 |

No evidence text available

reach
"AMP-activated protein kinase inhibitor reverses the effects of USP53 knockdown."
1 |

No evidence text available
Perfluorohexanesulfonic acid increases the amount of USP53. 1 / 1
1 |

No evidence text available
Peptidase affects USP53
| 1
| 1

reach
"Retinol binding protein 1 (RBP1) mRNA was upregulated by 2.6-fold in OF, and ubiquitin specific peptidase 53 (USP53) was upregulated by 2.3-fold."
Pantogab affects USP53
1 |
Pantogab increases the amount of USP53. 1 / 1
1 |

No evidence text available
Mercury(0) affects USP53
1 |
Mercury(0) decreases the amount of USP53. 1 / 1
1 |

No evidence text available
Melphalan affects USP53
1 |
Melphalan decreases the amount of USP53. 1 / 1
1 |

No evidence text available
Jinfukang affects USP53
1 |
Jinfukang decreases the amount of USP53. 1 / 1
1 |

No evidence text available
Indometacin affects USP53
1 |
Indometacin increases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-mir-548y decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-mir-548w decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-mir-548ak decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-mir-548ab decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-mir-4456 decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-mir-3973 decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-876-3p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-6838-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-6806-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-6792-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-6757-3p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-6504-3p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-5685 decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548o-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548j-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548i decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548h-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548d-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548c-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548bb-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548b-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548ay-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548au-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548as-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548ar-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548aq-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548ap-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548am-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548ae-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548ad-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-548a-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-545-3p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-503-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-497-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-497-3p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-4690-3p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-4524b-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-4524a-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-424-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-374b-3p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-323a-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-3120-3p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-30b-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-200a-3p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-195-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-186-3p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-15b-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-15a-5p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-141-3p decreases the amount of USP53. 1 / 1
1 |

No evidence text available
HBMSCs affects USP53
| 1
HBMSCs activates USP53. 1 / 1
| 1

reach
"The levels of unphosphorylated beta-catenin were higher in hBMSCs overexpressing USP53 than in the control."
1 |
Formaldehyde increases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Fluoranthene increases the amount of USP53. 1 / 1
1 |

No evidence text available
Dioxygen affects USP53
1 |
Dioxygen increases the amount of USP53. 1 / 1
1 |

No evidence text available
Dicrotophos affects USP53
1 |
Dicrotophos decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Dibutyl phthalate increases the amount of USP53. 1 / 1
1 |

No evidence text available
Diallyl trisulfide increases the amount of USP53. 1 / 1
1 |

No evidence text available
Copper atom affects USP53
1 |
Copper atom increases the amount of USP53. 1 / 1
1 |

No evidence text available
Choline affects USP53
1 |
Choline demethylates USP53. 1 / 1
1 |

No evidence text available
1 |
Chlorpyrifos decreases the amount of USP53. 1 / 1
1 |

No evidence text available
Calcitriol affects USP53
1 |
Calcitriol increases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Cadmium atom increases the amount of USP53. 1 / 1
1 |

No evidence text available
Bortezomib affects USP53
1 |
Bortezomib increases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Beta-D-glucose decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Benzo[a]pyrene increases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Aluminium atom decreases the amount of USP53. 1 / 1
1 |

No evidence text available
All-trans-retinoic acid increases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |
Aflatoxin B1 demethylates USP53. 1 / 1
1 |

No evidence text available
ZNF281 affects USP53
1 |
1 |

No evidence text available
YWHAH affects USP53
1 |
1 |

No evidence text available
YWHAG affects USP53
1 |
1 |

No evidence text available
YAE1 affects USP53
1 |
1 |

No evidence text available
XRCC5 affects USP53
1 |
1 |

No evidence text available
XAB2 affects USP53
1 |
1 |

No evidence text available
Ubiquitin affects USP53
| 1
| 1

reach
"Retinol binding protein 1 (RBP1) mRNA was upregulated by 2.6-fold in OF, and ubiquitin specific peptidase 53 (USP53) was upregulated by 2.3-fold."
USP54 affects USP53
| 1
| 1

sparser
"Also like Echinus, the USP53 and USP54 long forms are inactive in a deubiquitination assay using a model ubiquitin-β-gal fusion protein substrate [ xref ]."
| 1

reach
"We first examined the repair ability of Caki‐1 and 786‐O cells by wound healing assays; results showed that overexpression of USP53 significantly inhibited the ability of wound healing repair at 12 and 36 h for 786‐O and Caki‐1 (Figure 4A,B)."
USP53 affects tight junctions.914
| 1
Mutated USP53 activates tight junctions.914. 1 / 1
| 1

reach
"They can modulate barrier properties and mechanical stability of tight junctions.914 Therefore, USP53 mutation underlies a mouse deafness model."

reach
"By deubiquitinating IκBα, USP53 prevents NF-κB activation, suppresses the NF-κB signaling pathway, and inhibits ccRCC103."

reach
"RNA sequencing revealed that DKK1-induced SR-A upregulation in SMCs is dependent on Ubiquitin-specific Protease 53 (USP53), which bound to SR-A via its USP domain and cysteine at position 41, exerting deubiquitination to maintain the stability of the SR-A protein by removing the K48 ubiquitin chain and preventing proteasomal pathway degradation, thereby mediating the effect of DKK1 on lipid uptake in SMCs."
USP53 affects proteasome p-catenin
| 1
USP53 inhibits proteasome p-catenin. 1 / 1
| 1

eidos
"USP53 inhibits proteasome degradation of p-catenin by interacting with FBXO31 and enhance Wnt signaling ."
USP53 affects proteasome beta-catenin
| 1
USP53 inhibits proteasome beta-catenin. 1 / 1
| 1

eidos
"USP53 inhibits proteasome degradation of beta-catenin by interacting with F-box only protein 31 ( FBXO31 ) , thereby promoting osteogenic differentiation of human bone marrow-derived MSCs ( Baek et al ., 2021 ) ."
USP53 affects paclitaxel
| 1
| 1

reach
"Additionally, the knockdown of USP53 suppressed proliferation, EMT, and metastasis and enhanced the paclitaxel response of TNBC cells."
USP53 affects osteogenic differentiation human bone marrow-derived MSCs
| 1
USP53 activates osteogenic differentiation human bone marrow-derived MSCs. 1 / 1
| 1

eidos
"USP53 inhibits proteasome degradation of beta-catenin by interacting with F-box only protein 31 ( FBXO31 ) , thereby promoting osteogenic differentiation of human bone marrow-derived MSCs ( Baek et al ., 2021 ) ."

reach
"Li et al. reported that the expression of USP53 was up-regulated in the brain and spinal cord tissues of SD rats with chronic compressive injury, and knockout of the USP53 gene could alleviate neuropathic pain and inhibit inflammatory response in this model rats [79]."
USP53 affects hBMSCs
| 1
USP53 activates hBMSCs. 1 / 1
| 1

reach
"qRT-PCR and western blot analysis revealed that osteogenic marker expression levels in USP53 overexpressing hBMSCs were upregulated compared with those in control cells."
USP53 affects growth cells
| 1
USP53 inhibits growth cells. 1 / 1
| 1

eidos
"USP53 suppresses the proliferation and growth of ESCA cells in vitro and in vivo , whereas its knockdown exerts opposite effects ."
USP53 affects glycolysis lung adenocarcinoma
| 1
USP53 inhibits glycolysis lung adenocarcinoma. 1 / 1
| 1

eidos
"USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51-AKT1 signaling ."
USP53 affects fate mesenchymal cells
| 1
USP53 activates fate mesenchymal cells. 1 / 1
| 1

eidos
"Our data suggest that Usp53 modulates the fate of mesenchymal cells by impacting lineage selection ."
USP53 affects estrogen
| 1
| 1

reach
"Furthermore, the roles of USP53 in osteoporosis were examined in an OVX mouse model to induce estrogen deficiency related osteoporosis."

reach
"Transient depletion of USP12, USP46, and USP53 did not induce a senescence arrest."
| 1

reach
"Functionally, ectopic USP53 expression reduced cell proliferation and cell migration in vitro and vice versa."
USP53 affects cell cycle
| 1
| 1

reach
"Gain- and loss-of-function experiments demonstrated USP53 inhibited proliferation, clonogenesis, cell cycle and xenograft growth, as well as induced apoptosis and mitochondrial damage of breast cancer cells."
USP53 affects ccRCC103
| 1
USP53 inhibits ccRCC103. 1 / 1
| 1

reach
"By deubiquitinating IκBα, USP53 prevents NF-κB activation, suppresses the NF-κB signaling pathway, and inhibits ccRCC103."
| 1

reach
"At the cellular level, the ablation of Usp53 perturbs bone remodeling, augments osteoblast-dependent osteoclastogenesis, and increases osteoclast numbers."
| 1

reach
"Moreover, USP53-overexpressing human BMSCs markedly promote bone regeneration in murine calvaria bone defects."
USP53 affects autophagy
| 1
| 1

reach
"This suggests that knockdown of USP53 may increase the chemotherapy sensitivity of TNBC cells partly by promoting autophagy."
USP53 affects apoptosis cells
| 1
USP53 activates apoptosis cells. 1 / 1
| 1

eidos
"Finally , the overexpression of CYCS compensated for the decreased apoptotic rates in cells with USP53 knocked down , suggesting that USP53 induced the apoptosis in HCC cells through the deubiquitination of CYCS ."
USP53 affects ZNF281
1 |
1 |

No evidence text available
USP53 affects YWHAH
1 |
1 |

No evidence text available
USP53 affects YWHAG
1 |
1 |

No evidence text available
USP53 affects YAE1
1 |
1 |

No evidence text available
USP53 affects XRCC5
1 |
1 |

No evidence text available
USP53 affects XAB2
1 |
1 |

No evidence text available
USP53 affects Wnt
| 1
USP53 activates Wnt. 1 / 1
| 1

reach
"Additionally, we confirmed that USP53 overexpression promoted osteogenesis in hBMSCs by activating the Wnt and beta-catenin signaling pathway in vitro and that USP53 bound with FBXO31 during the osteogenic differentiation of hBMSCs."
USP53 affects Ubiquitin
| 1
USP53 decreases the amount of Ubiquitin. 1 / 1
| 1

reach
"We found that USP53 markedly downregulated Ub levels and inhibited SR-A degradation (Figure 7J, 7K)."
USP53 affects USP54
| 1
| 1

sparser
"Also like Echinus, the USP53 and USP54 long forms are inactive in a deubiquitination assay using a model ubiquitin-β-gal fusion protein substrate [ xref ]."
USP53 affects USP53
| 1
USP53 decreases the amount of USP53. 1 / 1
| 1

reach
"We further analyzed the expression of USP53 in TCGA‐KIRC database, consistent with GEO's results, the expression of USP53 in ccRCC is reduced (Figure 1B)."
USP53 affects USP44
| 1
| 1

sparser
"USP44 and USP53 interacted with ATCN7L3."
USP53 affects USP domain
| 1
USP53 binds MSR1 and USP domain. 1 / 1
| 1

reach
"RNA sequencing revealed that DKK1-induced SR-A upregulation in SMCs is dependent on Ubiquitin-specific Protease 53 (USP53), which bound to SR-A via its USP domain and cysteine at position 41, exerting deubiquitination to maintain the stability of the SR-A protein by removing the K48 ubiquitin chain and preventing proteasomal pathway degradation, thereby mediating the effect of DKK1 on lipid uptake in SMCs."
USP53 affects UBC
1 |
1 |

No evidence text available
USP53 affects U2SURP
1 |
1 |

No evidence text available
USP53 affects TUFM
1 |
1 |

No evidence text available
USP53 affects TRIP12
1 |
1 |

No evidence text available
USP53 affects TNRC6A
1 |
1 |

No evidence text available
USP53 affects TMOD2
1 |
1 |

No evidence text available
USP53 affects TGM3
1 |
1 |

No evidence text available
USP53 affects TCP1
1 |
1 |

No evidence text available
USP53 affects TCHP
1 |
1 |

No evidence text available
USP53 affects TCEA1
| 1
| 1

sparser
"To investigate the upstream molecular mechanisms by which EtOH elevates USP53 transcription, we employed 4 transcription factor (TF) prediction platforms—JASPAR, ChIP Atlas, GTRD, and ENCODE—to identify candidate TFs potentially binding to the USP53 promoter."
| 1
USP53 increases the amount of Subcutaneous Fat. 1 / 1
| 1

reach
"Fifty‐one genes in the community were strong predictors (VIP >1) among which STK17B, USP53, and MAN1A1 contributed heavily to this relationship, see Figure 2b,e. SAT expression of the “Glucose‐insulin‐AMPK” community showed significant predictive value against prevalence of T2D, with higher expression among individuals diagnosed with T2D (p < 0.001) in both SM muscle and SAT (Figure 2c,d)."
USP53 affects SYNGAP1
1 |
1 |

No evidence text available
USP53 affects SYN2
1 |
1 |

No evidence text available
USP53 affects SUGP2
1 |
1 |

No evidence text available
USP53 affects SPTBN2
1 |
1 |

No evidence text available
USP53 affects SNAI1
| 1
USP53 increases the amount of SNAI1. 1 / 1
| 1

reach
"Knockdown of USP53 decreased Snail1 and N-cadherin expression levels and increased E-cadherin expression levels in MDA-MB-231 cells (Figure 3e)."
USP53 affects SMAD5
| 1
| 1

sparser
"Co-IP analysis found that SMAD5 level was enriched in anti-USP53, and sh-USP53 reduced the levels of SMAD5 and USP53 in anti-USP53 (Supplementary Fig.  xref ), suggesting that USP53 might bound to SMAD5 protein (Fig.  xref E)."
USP53 affects SLTM
1 |
1 |

No evidence text available
USP53 affects SLC25A3
1 |
1 |

No evidence text available
USP53 affects SKP1
| 1
| 1

sparser
"First, we examined the mechanism through which FBXO31 regulated the stability of β-catenin, a key mediator of the Wnt signaling pathway xref and bone formation during osteogenic differentiation xref , using co-IP and western blot assays with wild-type FBXO31 and myc-FBXO31ΔF. As shown in Fig. xref , FBXO31 specifically interacted with β-catenin, Skp1, and USP53."
USP53 affects SFN
1 |
1 |

No evidence text available
USP53 affects SCCPDH
1 |
1 |

No evidence text available
USP53 affects SAMD4B
1 |
1 |

No evidence text available
USP53 affects RPTOR
1 |
1 |

No evidence text available
USP53 affects RPS6
1 |
1 |

No evidence text available
USP53 affects RPS15A
1 |
1 |

No evidence text available
USP53 affects RPL5
1 |
1 |

No evidence text available
USP53 affects RPL26
1 |
1 |

No evidence text available
USP53 affects RPL23
1 |
1 |

No evidence text available
USP53 affects RFC1
1 |
1 |

No evidence text available
USP53 affects RELA
| 1
USP53 inhibits RELA. 1 / 1
| 1

reach
"USP53 can inhibit the complex of p50 and p65 by deubiquitinizing IκBα, thereby inhibiting the activity of the NF-κB pathway and ultimately inhibiting the proliferation and metastasis of ccRCC [92]."
USP53 affects RBM28
1 |
1 |

No evidence text available
USP53 affects RAD50
1 |
1 |

No evidence text available
USP53 affects RAB3D
1 |
1 |

No evidence text available
| 1

reach
"Cell proliferation assays showed that USP53 knockdown inhibited cell proliferation and increased chemosensitivity to PTX in MDA-MB-231 cells (Figure 7c)."
USP53 affects PYGB
1 |
1 |

No evidence text available
USP53 affects PSMA6
1 |
1 |

No evidence text available
USP53 affects PRPF31
1 |
1 |

No evidence text available
USP53 affects PPP2R1B
1 |
1 |

No evidence text available
USP53 affects PLEC
1 |
1 |

No evidence text available
USP53 affects PKP3
1 |
1 |

No evidence text available
USP53 affects PIP
1 |
1 |

No evidence text available
USP53 affects PHB1
1 |
1 |

No evidence text available
USP53 affects PFIC7
| 1
USP53 activates PFIC7. 1 / 1
| 1

reach
"PFIC7 is caused by variants in the USP53 gene, which encodes for Inactive ubiquitin carboxyl-terminal-hydrolase-53, involved in the degradation of proteins; the phenotype related to USP53 mutation is probably related to a defective tight junction complex."
USP53 affects PDCD6IP
1 |
1 |

No evidence text available
USP53 affects PCGF6
1 |
1 |

No evidence text available
USP53 affects PCCA
1 |
1 |

No evidence text available
USP53 affects PC
1 |
1 |

No evidence text available
USP53 affects Obesity
| 1
USP53 activates Obesity. 1 / 1
| 1

reach
"Since USP2, 7, 15, 19, and 20 stimulate either adipogenesis or lipid synthesis, they are likely to cause obesity, while USP53 might be restorative for obesity."
USP53 affects NUP98
1 |
1 |

No evidence text available
USP53 affects NUP214
1 |
1 |

No evidence text available
USP53 affects NOP56
1 |
1 |

No evidence text available
USP53 affects NOP14
1 |
1 |

No evidence text available
USP53 affects NOC2L
1 |
1 |

No evidence text available
USP53 affects NINL
1 |
1 |

No evidence text available
USP53 affects NFE2L2
| 1
USP53 increases the amount of NFE2L2. 1 / 1
| 1

reach
"A high expression of USP53 increases the expression of Nrf2 in esophageal cancer Eca109 cells, thus leading to radiotherapy resistance."
USP53 affects NECTIN2
1 |
1 |

No evidence text available

eidos
"USP53 also inhibits glycolysis , oxidative metabolism , and mitochondrial dynamics ."
USP53 affects MTHFD1
1 |
1 |

No evidence text available
USP53 affects MSH6
1 |
1 |

No evidence text available
USP53 affects MKI67
1 |
1 |

No evidence text available
USP53 affects MCM7
1 |
1 |

No evidence text available
USP53 affects MCM4
1 |
1 |

No evidence text available
USP53 affects MCCC1
1 |
1 |

No evidence text available
USP53 affects MARVELD2
| 1
USP53 deubiquitinates MARVELD2. 1 / 1
| 1

reach
"Importantly, global levels of MARVELD2 remained unchanged (Fig. 3i), which supports the notion that nondegradative ubiquitination is being regulated by USP53.To test whether USP53 can deubiquitinate MARVELD2, we devised a workflow in which ubiquitinated proteins are enriched and then separated from the high-affinity OtUBD reagent by elution under acidic conditions."
USP53 affects KRT8
1 |
1 |

No evidence text available
USP53 affects KRT77
1 |
1 |

No evidence text available
USP53 affects KRT18
1 |
1 |

No evidence text available
USP53 affects KDELR1
1 |
1 |

No evidence text available
USP53 affects IREB2
1 |
1 |

No evidence text available
USP53 affects INS
| 1
USP53 increases the amount of INS. 1 / 1
| 1

reach
"Fifty‐one genes in the community were strong predictors (VIP >1) among which STK17B, USP53, and MAN1A1 contributed heavily to this relationship, see Figure 2b,e. SAT expression of the “Glucose‐insulin‐AMPK” community showed significant predictive value against prevalence of T2D, with higher expression among individuals diagnosed with T2D (p < 0.001) in both SM muscle and SAT (Figure 2c,d)."
USP53 affects IMP3
1 |
1 |

No evidence text available
USP53 affects IKBKB
| 1
USP53 leads to the dephosphorylation of IKBKB. 1 / 1
| 1

reach
"USP53 overexpression decreased the phosphorylation of IKKbeta and P65 in both Caki-1 and 786-O cells, and the expression of IkappaBalpha was increased."
USP53 affects IFNLR1
1 |
1 |

No evidence text available
| 1
| 1

reach
"Mutations in the USP53 gene in humans can cause cholestasis [4,5,6], hearing loss [7], and other conditions."
USP53 affects HRAS
1 |
1 |

No evidence text available
USP53 affects HP1BP3
1 |
1 |

No evidence text available
USP53 affects HNRNPL
1 |
1 |

No evidence text available
USP53 affects HNRNPA1
1 |
1 |

No evidence text available
USP53 affects HELZ
1 |
1 |

No evidence text available
USP53 affects HELLS
1 |
1 |

No evidence text available
USP53 affects HCFC1
1 |
1 |

No evidence text available
USP53 affects GTPBP4
1 |
1 |

No evidence text available
USP53 affects GTF2F2
1 |
1 |

No evidence text available
USP53 affects GRB2
1 |
1 |

No evidence text available
USP53 affects GPATCH4
1 |
1 |

No evidence text available
USP53 affects GOT2
1 |
1 |

No evidence text available
USP53 affects GNL2
1 |
1 |

No evidence text available
USP53 affects FTSJ3
1 |
1 |

No evidence text available
USP53 affects FLNC
1 |
1 |

No evidence text available
USP53 affects FKBP51/RhoA/ROCK
| 1
USP53 activates FKBP51/RhoA/ROCK. 1 / 1
| 1

reach
"Their study demonstrated that USP53 aggravated chronic compressive injury-induced neuropathic pain by activating the FKBP51/RhoA/ROCK signaling pathway.José et al. identified a variant in USP53 (p.Cys228Arg) as an underlying cause of schizophrenia [66]."
USP53 affects FKBP51
| 1
USP53 binds FKBP51. 1 / 1
| 1

sparser
"Zhao et al. showed that USP53 interacted with FKBP51 in lung adenocarcinoma cells, and induced apoptosis via the AKT pathway [ xref ]."
USP53 affects FBL
1 |
1 |

No evidence text available
USP53 affects FASN
1 |
1 |

No evidence text available
USP53 affects EXOSC10
1 |
1 |

No evidence text available
USP53 affects ESCA
| 1
USP53 inhibits ESCA. 1 / 1
| 1

reach
"Our study reveals that USP53 is activated by H3K27 acetylation and suppresses ESCA progression by regulating cell growth and metabolism."
USP53 affects EPRS1
1 |
1 |

No evidence text available
USP53 affects EPPK1
1 |
1 |

No evidence text available
USP53 affects ELOA
1 |
1 |

No evidence text available
USP53 affects EIF2AK2
1 |
1 |

No evidence text available
USP53 affects EEA1
1 |
1 |

No evidence text available
USP53 affects Disease
| 1
| 1

reach
"Loss of USP53 up-regulates RANKL expression, promotes the cytogenesis and functional activity of osteoclasts, and triggers osteodestructive diseases."
USP53 affects DYNC1H1
1 |
1 |

No evidence text available
USP53 affects DSG1
1 |
1 |

No evidence text available
USP53 affects DNTTIP2
1 |
1 |

No evidence text available
USP53 affects DNM1
1 |
1 |

No evidence text available
USP53 affects DNA Damage
| 1
| 1

reach
"Knockdown of USP53 followed by irradiation can cause G2/M phase arrest and inhibit DNA damage repair of human SiHa cells, resulting in a decreased cell survival rate."
USP53 affects DKK1
| 1
USP53 activates DKK1. 1 / 1
| 1

reach
"To determine whether USP53 mediates the effects of endothelial DKK1 on SMC-derived foam cell formation in vivo, the neutral lipid stain BODIPY493/503 and the leukocyte marker CD45 were visualized by fluorescence microscopy to distinguish between foam cell populations derived from leukocytes (macrophage-derived) and non-leukocytes (SMC-derived) in the atherosclerotic lesions of the LCA.The CD45 /BODIPY493/503 cell population represented the SMC-derived foam cells."
USP53 affects DDX46
1 |
1 |

No evidence text available
USP53 affects DDX42
1 |
1 |

No evidence text available
USP53 affects DDX3Y
1 |
1 |

No evidence text available
USP53 affects DDX24
1 |
1 |

No evidence text available
USP53 affects DDX18
1 |
1 |

No evidence text available
USP53 affects DAB1
1 |
1 |

No evidence text available
| 1
| 1

reach
"Cheng et al. [60] reported that USP53 inhibited the proliferation and growth of esophageal carcinoma cells in vitro and in vivo, and that USP53 activation by H3K27 acetylation modulates cell viability via the AMPK signaling pathway."

reach
"USP53 induces apoptosis of hepatocellular carcinoma cells through deubiquitination of cytochrome C [8] and is a tumor suppressive factor in esophageal carcinoma [9], lung adenocarcinoma [10], and renal clear cell carcinoma [11], but it has a significant inhibitory effect on the radiosensitivity of human cervical cancer [12]."
USP53 affects CTSH
1 |
1 |

No evidence text available
USP53 affects CSTA
1 |
1 |

No evidence text available
USP53 affects CREG2
1 |
1 |

No evidence text available
USP53 affects CPNE7
1 |
1 |

No evidence text available
USP53 affects COPB1
1 |
1 |

No evidence text available
USP53 affects COP1
1 |
1 |

No evidence text available
USP53 affects CHAMP1
1 |
1 |

No evidence text available
USP53 affects CDH2
| 1
USP53 increases the amount of CDH2. 1 / 1
| 1

reach
"Knockdown of USP53 decreased Snail1 and N-cadherin expression levels and increased E-cadherin expression levels in MDA-MB-231 cells (Figure 3e)."
USP53 affects CAT
1 |
1 |

No evidence text available
USP53 affects CASP14
1 |
1 |

No evidence text available
USP53 affects CAMK2A
1 |
1 |

No evidence text available
| 1

reach
"To assess whether USP53 promotes the growth of breast tumors in vivo, we constructed an MDA-MB-231 cell line with stable shUSP53 expression and verified the USP53 expression levels through Western blotting (Figure 2i)."
USP53 affects Bglap2
| 1
USP53 decreases the amount of Bglap2. 1 / 1
| 1

reach
"Usp53 knockdown in ST2 stromal cells stimulated expression of the osteoblastic markers Bglap2 (Osteocalcin) and Alpl (Alkaline phosphatase) and inhibited expression of the adipogenic markers Pparg and Cebpa."

reach
"USP53 enhances osteogenic function and differentiation in human BMSCs by stabilizing key proteins associated with osteogenic differentiation and regulating the BMP signaling pathway."
USP53 affects BLMH
1 |
1 |

No evidence text available
USP53 affects BICD2
1 |
1 |

No evidence text available
USP53 affects BICD1
1 |
1 |

No evidence text available
USP53 affects BAZ1B
1 |
1 |

No evidence text available

reach
"As reported previously, USP53 induced the apoptosis of lung adenocarcinoma cells through deubiquitination of FKBP51 [8]."
USP53 affects Ad
| 1
| 1

sparser
"Mechanistically, we found that neither siUSP53 nor Ad-USP53 affected SR-A mRNA level (Figure xref A, 7B)."
USP53 affects AZGP1
1 |
1 |

No evidence text available
USP53 affects ATP2A2
1 |
1 |

No evidence text available
USP53 affects ARG1
1 |
1 |

No evidence text available
USP53 affects AP3D1
1 |
1 |

No evidence text available
USP53 affects ANXA2P2
1 |
1 |

No evidence text available
USP53 affects ANKRD17
1 |
1 |

No evidence text available
USP53 affects ALPL
| 1
USP53 decreases the amount of ALPL. 1 / 1
| 1

reach
"Usp53 knockdown in ST2 stromal cells stimulated expression of the osteoblastic markers Bglap2 (Osteocalcin) and Alpl (Alkaline phosphatase) and inhibited expression of the adipogenic markers Pparg and Cebpa."
USP53 affects ALKBH5
1 |
1 |

No evidence text available
USP53 affects ALDH18A1
1 |

No evidence text available
USP53 affects AHSA1
1 |
1 |

No evidence text available
USP53 affects ACIN1
1 |
1 |

No evidence text available
USP53 affects ACE2
1 |
1 |

No evidence text available
USP53 affects ACACB
1 |
1 |

No evidence text available
USP53 affects ACACA
1 |
1 |

No evidence text available

reach
"Additionally, knockdown of USP53 decreased ALP and Alizarin Red S staining intensity as well as ALP activity."
USP44 affects USP53
| 1
| 1

sparser
"USP44 and USP53 interacted with ATCN7L3."
USP affects USP53
| 1
USP activates mutated USP53. 1 / 1
| 1

reach
"Taken together, these data demonstrate the importance of the unique active site arrangement in both USP DUBs for catalytic activity and enable the structural rationalization of USP53 mutations associated with disease (Supplementary Table 1)."
USP domain affects USP53
| 1
USP53 binds MSR1 and USP domain. 1 / 1
| 1

reach
"RNA sequencing revealed that DKK1-induced SR-A upregulation in SMCs is dependent on Ubiquitin-specific Protease 53 (USP53), which bound to SR-A via its USP domain and cysteine at position 41, exerting deubiquitination to maintain the stability of the SR-A protein by removing the K48 ubiquitin chain and preventing proteasomal pathway degradation, thereby mediating the effect of DKK1 on lipid uptake in SMCs."
UBC affects USP53
1 |
1 |

No evidence text available
U2SURP affects USP53
1 |
1 |

No evidence text available
Tobacco Smoke Pollution increases the amount of USP53. 1 / 1
1 |

No evidence text available
TUFM affects USP53
1 |
1 |

No evidence text available
TRIP12 affects USP53
1 |
1 |

No evidence text available
TNRC6A affects USP53
1 |
1 |

No evidence text available
TMOD2 affects USP53
1 |
1 |

No evidence text available
TJP2 affects TJP1
| 1
USP53 binds TJP1 and TJP2. 1 / 1
| 1

sparser
"Instead of binding with Ub, USP53 interacts with ZO-1 and ZO-2 as a part of the tight junction complex (Kazmierczak et al., xref )."
TGM3 affects USP53
1 |
1 |

No evidence text available
TCP1 affects USP53
1 |
1 |

No evidence text available
TCHP affects USP53
1 |
1 |

No evidence text available
TCEA1 affects USP53
| 1
| 1

sparser
"To investigate the upstream molecular mechanisms by which EtOH elevates USP53 transcription, we employed 4 transcription factor (TF) prediction platforms—JASPAR, ChIP Atlas, GTRD, and ENCODE—to identify candidate TFs potentially binding to the USP53 promoter."
SYNGAP1 affects USP53
1 |
1 |

No evidence text available
SYN2 affects USP53
1 |
1 |

No evidence text available
SUGP2 affects USP53
1 |
1 |

No evidence text available
SPTBN2 affects USP53
1 |
1 |

No evidence text available
SMC affects USP53
| 1
SMC increases the amount of USP53. 1 / 1
| 1

sparser
"We observed significantly increased USP53 transcription in rDKK1-treated SMCs previously ( xref E), implying that USP53 expression may be regulated by DKK1 at the transcription level primarily."
SMAD5 affects USP53
| 1
| 1

sparser
"Co-IP analysis found that SMAD5 level was enriched in anti-USP53, and sh-USP53 reduced the levels of SMAD5 and USP53 in anti-USP53 (Supplementary Fig.  xref ), suggesting that USP53 might bound to SMAD5 protein (Fig.  xref E)."
SLTM affects USP53
1 |
1 |

No evidence text available
SLC25A3 affects USP53
1 |
1 |

No evidence text available
SKP1 affects USP53
| 1
| 1

sparser
"First, we examined the mechanism through which FBXO31 regulated the stability of β-catenin, a key mediator of the Wnt signaling pathway xref and bone formation during osteogenic differentiation xref , using co-IP and western blot assays with wild-type FBXO31 and myc-FBXO31ΔF. As shown in Fig. xref , FBXO31 specifically interacted with β-catenin, Skp1, and USP53."
SFN affects USP53
1 |
1 |

No evidence text available
SCCPDH affects USP53
1 |
1 |

No evidence text available
SAMD4B affects USP53
1 |
1 |

No evidence text available
RPTOR affects USP53
1 |
1 |

No evidence text available
RPS6 affects USP53
1 |
1 |

No evidence text available
RPS15A affects USP53
1 |
1 |

No evidence text available
RPL5 affects USP53
1 |
1 |

No evidence text available
RPL26 affects USP53
1 |
1 |

No evidence text available
RPL23 affects USP53
1 |
1 |

No evidence text available
RFC1 affects USP53
1 |
1 |

No evidence text available
RBM28 affects USP53
1 |
1 |

No evidence text available
RAD50 affects USP53
1 |
1 |

No evidence text available
RAB3D affects USP53
1 |
1 |

No evidence text available
PYGB affects USP53
1 |
1 |

No evidence text available
PTH affects USP53
| 1
PTH activates USP53. 1 / 1
| 1

sparser
"The mutation abrogated the PTH-induced activation of the cloned Usp53 fragment, resulting in > 50% reduction in the promoter activity (Fig.  xref A, grey bars )."
PSMA6 affects USP53
1 |
1 |

No evidence text available
PRPF31 affects USP53
1 |
1 |

No evidence text available
PPP2R1B affects USP53
1 |
1 |

No evidence text available
PLEC affects USP53
1 |
1 |

No evidence text available
PKP3 affects USP53
1 |
1 |

No evidence text available
PIP affects USP53
1 |
1 |

No evidence text available
PHB1 affects USP53
1 |
1 |

No evidence text available
PDCD6IP affects USP53
1 |
1 |

No evidence text available
PCGF6 affects USP53
1 |
1 |

No evidence text available
PCCA affects USP53
1 |
1 |

No evidence text available
PC affects USP53
1 |
1 |

No evidence text available
USP53 is modified
| 1
USP53 is phosphorylated. 1 / 1
| 1

sparser
"2.1) found seven heterozygous USP53 p."
NUP98 affects USP53
1 |
1 |

No evidence text available
NUP214 affects USP53
1 |
1 |

No evidence text available
NSC 689534 affects USP53
1 |
NSC 689534 increases the amount of USP53. 1 / 1
1 |

No evidence text available
NOP56 affects USP53
1 |
1 |

No evidence text available
NOP14 affects USP53
1 |
1 |

No evidence text available
NOC2L affects USP53
1 |
1 |

No evidence text available
NINL affects USP53
1 |
1 |

No evidence text available
NECTIN2 affects USP53
1 |
1 |

No evidence text available
MYO5B affects USP53
| 1
MYO5B activates USP53. 1 / 1
| 1

reach
"This is important to emphasize to have PFIC4 patients with native liver adequately screened.Patients with less frequent, novel, and yet not fully understood types of PFIC-associated genetic mutations (eg, nuclear receptor subfamily 1 group H, MYO5B, KIF12, lipolysis stimulated lipoprotein receptor, ubiquitin-specific peptidase 53, and WD repeat domain 83 opposite strand gene) were not included in this study.This systematic review has certain limitations that are, to some extent, based on the rarity of the diseases included."
MTHFD1 affects USP53
1 |
1 |

No evidence text available
MSR1 affects USP domain, and USP53
| 1
USP53 binds MSR1 and USP domain. 1 / 1
| 1

reach
"RNA sequencing revealed that DKK1-induced SR-A upregulation in SMCs is dependent on Ubiquitin-specific Protease 53 (USP53), which bound to SR-A via its USP domain and cysteine at position 41, exerting deubiquitination to maintain the stability of the SR-A protein by removing the K48 ubiquitin chain and preventing proteasomal pathway degradation, thereby mediating the effect of DKK1 on lipid uptake in SMCs."
MSH6 affects USP53
1 |
1 |

No evidence text available
MKI67 affects USP53
1 |
1 |

No evidence text available
MIR646 affects USP53
1 |
MIR646 decreases the amount of USP53. 1 / 1
1 |

No evidence text available
MIR559 affects USP53
1 |
MIR559 decreases the amount of USP53. 1 / 1
1 |

No evidence text available
MCM7 affects USP53
1 |
1 |

No evidence text available
MCM4 affects USP53
1 |
1 |

No evidence text available
MCCC1 affects USP53
1 |
1 |

No evidence text available
1 |
L-methionine demethylates USP53. 1 / 1
1 |

No evidence text available
KRT8 affects USP53
1 |
1 |

No evidence text available
KRT77 affects USP53
1 |
1 |

No evidence text available
KRT18 affects USP53
1 |
1 |

No evidence text available
KIF12 affects USP53
| 1
KIF12 activates USP53. 1 / 1
| 1

reach
"This is important to emphasize to have PFIC4 patients with native liver adequately screened.Patients with less frequent, novel, and yet not fully understood types of PFIC-associated genetic mutations (eg, nuclear receptor subfamily 1 group H, MYO5B, KIF12, lipolysis stimulated lipoprotein receptor, ubiquitin-specific peptidase 53, and WD repeat domain 83 opposite strand gene) were not included in this study.This systematic review has certain limitations that are, to some extent, based on the rarity of the diseases included."
KDELR1 affects USP53
1 |
1 |

No evidence text available
JUN_family affects USP53
| 1
| 1

sparser
"We then assessed the JUN-CREB activation of the Usp53 cloned fragment in Naca -knockdown cells."
IREB2 affects USP53
1 |
1 |

No evidence text available
IMP3 affects USP53
1 |
1 |

No evidence text available
IFNLR1 affects USP53
1 |
1 |

No evidence text available
HYCC1 affects USP53
| 1
HYCC1 activates USP53. 1 / 1
| 1

reach
"Furthermore, orthotopic tumors derived from the USP53-overexpressing HCC cells showed weaker PET-CT signals compared to control group, which were derived from the same HCCLM3 cells without USP53 overexpression (Fig. 3D, E)."
HRAS affects USP53
1 |
1 |

No evidence text available
HP1BP3 affects USP53
1 |
1 |

No evidence text available
HNRNPL affects USP53
1 |
1 |

No evidence text available
HNRNPA1 affects USP53
1 |
1 |

No evidence text available
HELZ affects USP53
1 |
1 |

No evidence text available
HELLS affects USP53
1 |
1 |

No evidence text available
HCFC1 affects USP53
1 |
1 |

No evidence text available
Gentamicins affects USP53
1 |
Gentamicins increases the amount of USP53. 1 / 1
1 |

No evidence text available
GTPBP4 affects USP53
1 |
1 |

No evidence text available
GTF2F2 affects USP53
1 |
1 |

No evidence text available
GSK-J4 affects USP53
1 |
GSK-J4 increases the amount of USP53. 1 / 1
1 |

No evidence text available
GRB2 affects USP53
1 |
1 |

No evidence text available
GPATCH4 affects USP53
1 |
1 |

No evidence text available
GOT2 affects USP53
1 |
1 |

No evidence text available
GNL2 affects USP53
1 |
1 |

No evidence text available
FTSJ3 affects USP53
1 |
1 |

No evidence text available
FLNC affects USP53
1 |
1 |

No evidence text available
FKBP51 affects USP53
| 1
USP53 binds FKBP51. 1 / 1
| 1

sparser
"Zhao et al. showed that USP53 interacted with FKBP51 in lung adenocarcinoma cells, and induced apoptosis via the AKT pathway [ xref ]."
FBXO31 affects SKP1
| 1
| 1

sparser
"First, we examined the mechanism through which FBXO31 regulated the stability of β-catenin, a key mediator of the Wnt signaling pathway xref and bone formation during osteogenic differentiation xref , using co-IP and western blot assays with wild-type FBXO31 and myc-FBXO31ΔF. As shown in Fig. xref , FBXO31 specifically interacted with β-catenin, Skp1, and USP53."
FBL affects USP53
1 |
1 |

No evidence text available
FASN affects USP53
1 |
1 |

No evidence text available
EXOSC10 affects USP53
1 |
1 |

No evidence text available
EPRS1 affects USP53
1 |
1 |

No evidence text available
EPPK1 affects USP53
1 |
1 |

No evidence text available
ELOA affects USP53
1 |
1 |

No evidence text available
EIF2AK2 affects USP53
1 |
1 |

No evidence text available
EEA1 affects USP53
1 |
1 |

No evidence text available

eidos
"AMP-activated protein kinase inhibitor reverses the effects of USP53 knockdown ."
DYNC1H1 affects USP53
1 |
1 |

No evidence text available
DSG1 affects USP53
1 |
1 |

No evidence text available
DNTTIP2 affects USP53
1 |
1 |

No evidence text available
DNM1 affects USP53
1 |
1 |

No evidence text available
DDX46 affects USP53
1 |
1 |

No evidence text available
DDX42 affects USP53
1 |
1 |

No evidence text available
DDX3Y affects USP53
1 |
1 |

No evidence text available
DDX24 affects USP53
1 |
1 |

No evidence text available
DDX18 affects USP53
1 |
1 |

No evidence text available
DAB1 affects USP53
1 |
1 |

No evidence text available
Cuprizon affects USP53
1 |
Cuprizon increases the amount of USP53. 1 / 1
1 |

No evidence text available
CTSH affects USP53
1 |
1 |

No evidence text available
CTNNB1 affects SKP1
| 1
| 1

sparser
"First, we examined the mechanism through which FBXO31 regulated the stability of β-catenin, a key mediator of the Wnt signaling pathway xref and bone formation during osteogenic differentiation xref , using co-IP and western blot assays with wild-type FBXO31 and myc-FBXO31ΔF. As shown in Fig. xref , FBXO31 specifically interacted with β-catenin, Skp1, and USP53."
CSTA affects USP53
1 |
1 |

No evidence text available
CREG2 affects USP53
1 |
1 |

No evidence text available
CPNE7 affects USP53
1 |
1 |

No evidence text available
COPB1 affects USP53
1 |
1 |

No evidence text available
COP1 affects USP53
1 |
1 |

No evidence text available
CHAMP1 affects USP53
1 |
1 |

No evidence text available
CDH1 affects USP53
1 |
1 |

No evidence text available
CAT affects USP53
1 |
1 |

No evidence text available
CASP14 affects USP53
1 |
1 |

No evidence text available
CAMK2A affects USP53
1 |
1 |

No evidence text available
BLMH affects USP53
1 |
1 |

No evidence text available
BICD2 affects USP53
1 |
1 |

No evidence text available
BICD1 affects USP53
1 |
1 |

No evidence text available
BAZ1B affects USP53
1 |
1 |

No evidence text available
1 |
Air Pollutants decreases the amount of USP53. 1 / 1
1 |

No evidence text available
Ad affects USP53
| 1
| 1

sparser
"Mechanistically, we found that neither siUSP53 nor Ad-USP53 affected SR-A mRNA level (Figure xref A, 7B)."
Acrylamide affects USP53
1 |
Acrylamide increases the amount of USP53. 1 / 1
1 |

No evidence text available
AZGP1 affects USP53
1 |
1 |

No evidence text available
ATP2A2 affects USP53
1 |
1 |

No evidence text available
ARG1 affects USP53
1 |
1 |

No evidence text available
APOE mice affects USP53
| 1
APOE mice activates USP53. 1 / 1
| 1

reach
"To confirm the mediating role of USP53 in the effect of endothelial DKK1 on AS and SMC-derived foam cell formation in vivo, DKK1 /APOE mice were injected with recombinant AAV2 vectors that overexpressed SMCs-specific USP53 (AAV2-SM22α-USP53) or Control vector (AAV2-SM22α-Con) for 4 weeks (Figure 8A)."
AP3D1 affects USP53
1 |
1 |

No evidence text available
ANXA2P2 affects USP53
1 |
1 |

No evidence text available
ANKRD17 affects USP53
1 |
1 |

No evidence text available
AMPK affects USP53
| 1
AMPK inhibits USP53. 1 / 1
| 1

reach
"AMP-activated protein kinase inhibitor reverses the effects of USP53 knockdown."
ALKBH5 affects USP53
1 |
1 |

No evidence text available
ALDH18A1 affects USP53
1 |

No evidence text available
AHSA1 affects USP53
1 |
1 |

No evidence text available
ACIN1 affects USP53
1 |
1 |

No evidence text available
ACE2 affects USP53
1 |
1 |

No evidence text available
ACACB affects USP53
1 |
1 |

No evidence text available
ACACA affects USP53
1 |
1 |

No evidence text available
4-hydroxyphenyl retinamide increases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |

No evidence text available
1 |

No evidence text available
17alpha-ethynylestradiol increases the amount of USP53. 1 / 1
1 |

No evidence text available
1-methylanthracene increases the amount of USP53. 1 / 1
1 |

No evidence text available
1,2-dimethylhydrazine decreases the amount of USP53. 1 / 1
1 |

No evidence text available
4,4'-diaminodiphenylmethane decreases the amount of USP53. 1 / 1
1 |

No evidence text available
1 |

No evidence text available
1 |

No evidence text available